JP2024095759A - Retention agent for active ingredients - Google Patents
Retention agent for active ingredientsInfo
- Publication number
- JP2024095759A JP2024095759A JP2024062240A JP2024062240A JP2024095759A JP 2024095759 A JP2024095759 A JP 2024095759A JP 2024062240 A JP2024062240 A JP 2024062240A JP 2024062240 A JP2024062240 A JP 2024062240A JP 2024095759 A JP2024095759 A JP 2024095759A
- Authority
- JP
- Japan
- Prior art keywords
- oil
- mass
- water
- retention agent
- water emulsion
- Prior art date
Links
- 230000014759 maintenance of location Effects 0.000 title claims abstract description 68
- 239000004480 active ingredient Substances 0.000 title claims abstract description 64
- 239000007764 o/w emulsion Substances 0.000 claims abstract description 140
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 88
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 79
- 230000002209 hydrophobic effect Effects 0.000 claims abstract description 76
- 150000004676 glycans Chemical class 0.000 claims abstract description 65
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 63
- 239000005017 polysaccharide Substances 0.000 claims abstract description 63
- 230000008719 thickening Effects 0.000 claims abstract description 62
- 229920000858 Cyclodextrin Polymers 0.000 claims abstract description 56
- 239000000126 substance Substances 0.000 claims abstract description 56
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims abstract description 40
- 235000013305 food Nutrition 0.000 claims abstract description 36
- 235000013361 beverage Nutrition 0.000 claims abstract description 26
- 239000001993 wax Substances 0.000 claims abstract description 24
- 229920005989 resin Polymers 0.000 claims abstract description 22
- 239000011347 resin Substances 0.000 claims abstract description 22
- 229920001525 carrageenan Polymers 0.000 claims abstract description 18
- 239000000679 carrageenan Substances 0.000 claims abstract description 18
- 229940113118 carrageenan Drugs 0.000 claims abstract description 18
- 229920001285 xanthan gum Polymers 0.000 claims abstract description 18
- 235000010493 xanthan gum Nutrition 0.000 claims abstract description 18
- 239000000230 xanthan gum Substances 0.000 claims abstract description 18
- 229940082509 xanthan gum Drugs 0.000 claims abstract description 18
- 239000002537 cosmetic Substances 0.000 claims abstract description 14
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims abstract description 12
- 235000013804 distarch phosphate Nutrition 0.000 claims abstract description 12
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 claims abstract description 11
- 229920002581 Glucomannan Polymers 0.000 claims abstract description 11
- 229940046240 glucomannan Drugs 0.000 claims abstract description 11
- 229920002148 Gellan gum Polymers 0.000 claims abstract description 10
- 240000004584 Tamarindus indica Species 0.000 claims abstract description 10
- 235000004298 Tamarindus indica Nutrition 0.000 claims abstract description 10
- 235000010492 gellan gum Nutrition 0.000 claims abstract description 10
- 239000000216 gellan gum Substances 0.000 claims abstract description 10
- 229920000591 gum Polymers 0.000 claims abstract description 10
- 229920002907 Guar gum Polymers 0.000 claims abstract description 9
- 229920000161 Locust bean gum Polymers 0.000 claims abstract description 9
- 235000010417 guar gum Nutrition 0.000 claims abstract description 9
- 239000000665 guar gum Substances 0.000 claims abstract description 9
- 229960002154 guar gum Drugs 0.000 claims abstract description 9
- 235000010420 locust bean gum Nutrition 0.000 claims abstract description 9
- 239000000711 locust bean gum Substances 0.000 claims abstract description 9
- 229920001615 Tragacanth Polymers 0.000 claims abstract description 8
- ZNOZWUKQPJXOIG-XSBHQQIPSA-L [(2r,3s,4r,5r,6s)-6-[[(1r,3s,4r,5r,8s)-3,4-dihydroxy-2,6-dioxabicyclo[3.2.1]octan-8-yl]oxy]-4-[[(1r,3r,4r,5r,8s)-8-[(2s,3r,4r,5r,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-sulfonatooxyoxan-2-yl]oxy-4-hydroxy-2,6-dioxabicyclo[3.2.1]octan-3-yl]oxy]-5-hydroxy-2-( Chemical compound O[C@@H]1[C@@H](O)[C@@H](OS([O-])(=O)=O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H]2OC[C@H]1O[C@H](O[C@H]1[C@H]([C@@H](CO)O[C@@H](O[C@@H]3[C@@H]4OC[C@H]3O[C@H](O)[C@@H]4O)[C@@H]1O)OS([O-])(=O)=O)[C@@H]2O ZNOZWUKQPJXOIG-XSBHQQIPSA-L 0.000 claims abstract description 8
- 244000215068 Acacia senegal Species 0.000 claims abstract description 7
- 229920000084 Gum arabic Polymers 0.000 claims abstract description 7
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims abstract description 7
- 235000010489 acacia gum Nutrition 0.000 claims abstract description 7
- 239000000205 acacia gum Substances 0.000 claims abstract description 7
- 239000000305 astragalus gummifer gum Substances 0.000 claims abstract description 7
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims abstract description 7
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims abstract description 7
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims abstract description 7
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims abstract description 7
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims abstract description 7
- 229920000609 methyl cellulose Polymers 0.000 claims abstract description 7
- 235000010981 methylcellulose Nutrition 0.000 claims abstract description 7
- 239000001923 methylcellulose Substances 0.000 claims abstract description 7
- 229920001277 pectin Polymers 0.000 claims abstract description 7
- 235000010987 pectin Nutrition 0.000 claims abstract description 7
- 239000001814 pectin Substances 0.000 claims abstract description 7
- 239000001341 hydroxy propyl starch Substances 0.000 claims abstract description 6
- 235000013828 hydroxypropyl starch Nutrition 0.000 claims abstract description 6
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims abstract 2
- 239000000839 emulsion Substances 0.000 claims description 45
- 238000002156 mixing Methods 0.000 claims description 17
- 235000014593 oils and fats Nutrition 0.000 claims description 13
- 238000004519 manufacturing process Methods 0.000 claims description 9
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 claims description 6
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims description 6
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims description 6
- RFRMMZAKBNXNHE-UHFFFAOYSA-N 6-[4,6-dihydroxy-5-(2-hydroxyethoxy)-2-(hydroxymethyl)oxan-3-yl]oxy-2-(hydroxymethyl)-5-(2-hydroxypropoxy)oxane-3,4-diol Chemical compound CC(O)COC1C(O)C(O)C(CO)OC1OC1C(O)C(OCCO)C(O)OC1CO RFRMMZAKBNXNHE-UHFFFAOYSA-N 0.000 claims description 4
- 239000000825 pharmaceutical preparation Substances 0.000 claims 2
- 229940127557 pharmaceutical product Drugs 0.000 claims 2
- 239000000463 material Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 abstract description 37
- 239000003921 oil Substances 0.000 abstract description 30
- 230000000694 effects Effects 0.000 abstract description 25
- 239000003925 fat Substances 0.000 abstract description 16
- 235000010948 carboxy methyl cellulose Nutrition 0.000 abstract description 4
- 239000001768 carboxy methyl cellulose Substances 0.000 abstract description 4
- 239000008112 carboxymethyl-cellulose Substances 0.000 abstract description 4
- 238000010586 diagram Methods 0.000 abstract 1
- 235000019640 taste Nutrition 0.000 description 48
- -1 furcellaran Polymers 0.000 description 47
- 239000000203 mixture Substances 0.000 description 40
- 210000004209 hair Anatomy 0.000 description 32
- 239000000796 flavoring agent Substances 0.000 description 31
- 235000019634 flavors Nutrition 0.000 description 31
- 235000019198 oils Nutrition 0.000 description 29
- 238000011156 evaluation Methods 0.000 description 28
- 239000004615 ingredient Substances 0.000 description 26
- 239000000243 solution Substances 0.000 description 24
- 229940079593 drug Drugs 0.000 description 22
- 239000007864 aqueous solution Substances 0.000 description 19
- 210000000214 mouth Anatomy 0.000 description 17
- 229920001450 Alpha-Cyclodextrin Polymers 0.000 description 16
- 239000007788 liquid Substances 0.000 description 16
- HFHDHCJBZVLPGP-RWMJIURBSA-N alpha-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO HFHDHCJBZVLPGP-RWMJIURBSA-N 0.000 description 15
- 229940043377 alpha-cyclodextrin Drugs 0.000 description 15
- 235000019197 fats Nutrition 0.000 description 14
- 230000000052 comparative effect Effects 0.000 description 13
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 11
- 239000012071 phase Substances 0.000 description 11
- 241001465754 Metazoa Species 0.000 description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
- 235000014113 dietary fatty acids Nutrition 0.000 description 10
- 238000001035 drying Methods 0.000 description 10
- 239000000194 fatty acid Substances 0.000 description 10
- 229930195729 fatty acid Natural products 0.000 description 10
- 210000001519 tissue Anatomy 0.000 description 10
- 230000002265 prevention Effects 0.000 description 9
- 238000004945 emulsification Methods 0.000 description 8
- 239000003995 emulsifying agent Substances 0.000 description 8
- 230000037406 food intake Effects 0.000 description 8
- 239000000499 gel Substances 0.000 description 8
- 239000007787 solid Substances 0.000 description 8
- 230000001965 increasing effect Effects 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- 230000002708 enhancing effect Effects 0.000 description 6
- 210000000981 epithelium Anatomy 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 239000001257 hydrogen Substances 0.000 description 6
- 229910052739 hydrogen Inorganic materials 0.000 description 6
- 230000003993 interaction Effects 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 239000002562 thickening agent Substances 0.000 description 6
- HSHXDCVZWHOWCS-UHFFFAOYSA-N N'-hexadecylthiophene-2-carbohydrazide Chemical compound CCCCCCCCCCCCCCCCNNC(=O)c1cccs1 HSHXDCVZWHOWCS-UHFFFAOYSA-N 0.000 description 5
- 239000003242 anti bacterial agent Substances 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 239000000693 micelle Substances 0.000 description 5
- 235000019643 salty taste Nutrition 0.000 description 5
- 230000001953 sensory effect Effects 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 4
- 239000004166 Lanolin Substances 0.000 description 4
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 4
- 241000209140 Triticum Species 0.000 description 4
- 235000021307 Triticum Nutrition 0.000 description 4
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 4
- 239000008346 aqueous phase Substances 0.000 description 4
- 229960001950 benzethonium chloride Drugs 0.000 description 4
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 4
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 4
- 235000019388 lanolin Nutrition 0.000 description 4
- 239000000314 lubricant Substances 0.000 description 4
- 235000019271 petrolatum Nutrition 0.000 description 4
- 239000000049 pigment Substances 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 235000019633 pungent taste Nutrition 0.000 description 4
- 230000000717 retained effect Effects 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- 235000019583 umami taste Nutrition 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 239000004475 Arginine Substances 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 3
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 3
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 3
- 229920002125 Sokalan® Polymers 0.000 description 3
- 108010073771 Soybean Proteins Proteins 0.000 description 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 3
- 235000019658 bitter taste Nutrition 0.000 description 3
- 235000015218 chewing gum Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000001804 emulsifying effect Effects 0.000 description 3
- 239000010408 film Substances 0.000 description 3
- 239000003349 gelling agent Substances 0.000 description 3
- 235000013922 glutamic acid Nutrition 0.000 description 3
- 239000004220 glutamic acid Substances 0.000 description 3
- 229930182470 glycoside Natural products 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 238000000111 isothermal titration calorimetry Methods 0.000 description 3
- 229940039717 lanolin Drugs 0.000 description 3
- 239000002324 mouth wash Substances 0.000 description 3
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 3
- 235000019600 saltiness Nutrition 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 3
- 229940001941 soy protein Drugs 0.000 description 3
- 235000012424 soybean oil Nutrition 0.000 description 3
- 239000003549 soybean oil Substances 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 239000003381 stabilizer Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- FGGGERRYLOWIHE-UHFFFAOYSA-N 2-methyl-3-propan-2-ylphenol;2-methyl-5-propan-2-ylphenol Chemical compound CC(C)C1=CC=C(C)C(O)=C1.CC(C)C1=CC=CC(O)=C1C FGGGERRYLOWIHE-UHFFFAOYSA-N 0.000 description 2
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 2
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 2
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000195940 Bryophyta Species 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- 206010013911 Dysgeusia Diseases 0.000 description 2
- 239000004278 EU approved seasoning Substances 0.000 description 2
- 102000002322 Egg Proteins Human genes 0.000 description 2
- 108010000912 Egg Proteins Proteins 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 2
- 108010076876 Keratins Proteins 0.000 description 2
- 102000011782 Keratins Human genes 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 2
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 2
- 235000004347 Perilla Nutrition 0.000 description 2
- 244000124853 Perilla frutescens Species 0.000 description 2
- 239000004264 Petrolatum Substances 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- LOUPRKONTZGTKE-WZBLMQSHSA-N Quinine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-WZBLMQSHSA-N 0.000 description 2
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 2
- 239000006096 absorbing agent Substances 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 229960000458 allantoin Drugs 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 229960003121 arginine Drugs 0.000 description 2
- 235000009697 arginine Nutrition 0.000 description 2
- 235000021302 avocado oil Nutrition 0.000 description 2
- 239000008163 avocado oil Substances 0.000 description 2
- 229960000686 benzalkonium chloride Drugs 0.000 description 2
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 210000000621 bronchi Anatomy 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 229960001948 caffeine Drugs 0.000 description 2
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 2
- 239000010495 camellia oil Substances 0.000 description 2
- 235000019519 canola oil Nutrition 0.000 description 2
- 239000000828 canola oil Substances 0.000 description 2
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 2
- 239000004203 carnauba wax Substances 0.000 description 2
- 235000013869 carnauba wax Nutrition 0.000 description 2
- 229940082483 carnauba wax Drugs 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 239000005018 casein Substances 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 235000021240 caseins Nutrition 0.000 description 2
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 2
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 2
- 239000002738 chelating agent Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000007910 chewable tablet Substances 0.000 description 2
- 229940112822 chewing gum Drugs 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 235000019868 cocoa butter Nutrition 0.000 description 2
- 229940110456 cocoa butter Drugs 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- 239000000551 dentifrice Substances 0.000 description 2
- PFRGXCVKLLPLIP-UHFFFAOYSA-N diallyl disulfide Chemical compound C=CCSSCC=C PFRGXCVKLLPLIP-UHFFFAOYSA-N 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 239000007884 disintegrant Substances 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 229940012466 egg shell membrane Drugs 0.000 description 2
- 210000002969 egg yolk Anatomy 0.000 description 2
- 235000013345 egg yolk Nutrition 0.000 description 2
- 210000003238 esophagus Anatomy 0.000 description 2
- 239000010685 fatty oil Substances 0.000 description 2
- 235000012041 food component Nutrition 0.000 description 2
- 239000005417 food ingredient Substances 0.000 description 2
- 235000011194 food seasoning agent Nutrition 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 229960002989 glutamic acid Drugs 0.000 description 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 2
- 229960004949 glycyrrhizic acid Drugs 0.000 description 2
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 2
- 235000019410 glycyrrhizin Nutrition 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- 230000001339 gustatory effect Effects 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 2
- 235000011929 mousse Nutrition 0.000 description 2
- 229940051866 mouthwash Drugs 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- 210000003928 nasal cavity Anatomy 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 239000010466 nut oil Substances 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 239000004209 oxidized polyethylene wax Substances 0.000 description 2
- 235000013873 oxidized polyethylene wax Nutrition 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 238000003359 percent control normalization Methods 0.000 description 2
- 230000002688 persistence Effects 0.000 description 2
- 229940066842 petrolatum Drugs 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 239000004014 plasticizer Substances 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 150000004804 polysaccharides Polymers 0.000 description 2
- 239000001103 potassium chloride Substances 0.000 description 2
- 235000011164 potassium chloride Nutrition 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- 229940079889 pyrrolidonecarboxylic acid Drugs 0.000 description 2
- ARIWANIATODDMH-UHFFFAOYSA-N rac-1-monolauroylglycerol Chemical compound CCCCCCCCCCCC(=O)OCC(O)CO ARIWANIATODDMH-UHFFFAOYSA-N 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 210000003296 saliva Anatomy 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000002453 shampoo Substances 0.000 description 2
- 229920002545 silicone oil Polymers 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 229960002668 sodium chloride Drugs 0.000 description 2
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
- 235000019830 sodium polyphosphate Nutrition 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000000375 suspending agent Substances 0.000 description 2
- 235000007586 terpenes Nutrition 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- YAPQBXQYLJRXSA-UHFFFAOYSA-N theobromine Chemical compound CN1C(=O)NC(=O)C2=C1N=CN2C YAPQBXQYLJRXSA-UHFFFAOYSA-N 0.000 description 2
- 238000004448 titration Methods 0.000 description 2
- 210000003437 trachea Anatomy 0.000 description 2
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 2
- 229960000401 tranexamic acid Drugs 0.000 description 2
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 description 2
- 229960003500 triclosan Drugs 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- AUHDWARTFSKSAC-HEIFUQTGSA-N (2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)-2-(6-oxo-1H-purin-9-yl)oxolane-2-carboxylic acid Chemical compound [C@]1([C@H](O)[C@H](O)[C@@H](CO)O1)(N1C=NC=2C(O)=NC=NC12)C(=O)O AUHDWARTFSKSAC-HEIFUQTGSA-N 0.000 description 1
- ZSTLCHCDLIUXJE-ZGBAEQJLSA-N (2S,5S)-2-methylspiro[1,3-oxathiolane-5,3'-1-azabicyclo[2.2.2]octane] hydrate dihydrochloride Chemical compound O.Cl.Cl.C1S[C@@H](C)O[C@@]21C(CC1)CCN1C2.C1S[C@@H](C)O[C@@]21C(CC1)CCN1C2 ZSTLCHCDLIUXJE-ZGBAEQJLSA-N 0.000 description 1
- OMDQUFIYNPYJFM-XKDAHURESA-N (2r,3r,4s,5r,6s)-2-(hydroxymethyl)-6-[[(2r,3s,4r,5s,6r)-4,5,6-trihydroxy-3-[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@H](O)[C@H](O)O1 OMDQUFIYNPYJFM-XKDAHURESA-N 0.000 description 1
- WMFHUUKYIUOHRA-UHFFFAOYSA-N (3-phenoxyphenyl)methanamine;hydrochloride Chemical compound Cl.NCC1=CC=CC(OC=2C=CC=CC=2)=C1 WMFHUUKYIUOHRA-UHFFFAOYSA-N 0.000 description 1
- OQWKEEOHDMUXEO-UHFFFAOYSA-N (6)-shogaol Natural products CCCCCC=CC(=O)CCC1=CC=C(O)C(OC)=C1 OQWKEEOHDMUXEO-UHFFFAOYSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- OKMWKBLSFKFYGZ-UHFFFAOYSA-N 1-behenoylglycerol Chemical compound CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(O)CO OKMWKBLSFKFYGZ-UHFFFAOYSA-N 0.000 description 1
- QHZLMUACJMDIAE-SFHVURJKSA-N 1-hexadecanoyl-sn-glycerol Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)CO QHZLMUACJMDIAE-SFHVURJKSA-N 0.000 description 1
- WECGLUPZRHILCT-GSNKCQISSA-N 1-linoleoyl-sn-glycerol Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OC[C@@H](O)CO WECGLUPZRHILCT-GSNKCQISSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- JNAYPSWVMNJOPQ-UHFFFAOYSA-N 2,3-bis(16-methylheptadecanoyloxy)propyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C JNAYPSWVMNJOPQ-UHFFFAOYSA-N 0.000 description 1
- 239000000263 2,3-dihydroxypropyl (Z)-octadec-9-enoate Substances 0.000 description 1
- KKDLMTFRMQVLMO-UHFFFAOYSA-N 2-heptylundecyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CCCCCCC)CCCCCCCCC KKDLMTFRMQVLMO-UHFFFAOYSA-N 0.000 description 1
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 description 1
- RZRNAYUHWVFMIP-GDCKJWNLSA-N 3-oleoyl-sn-glycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](O)CO RZRNAYUHWVFMIP-GDCKJWNLSA-N 0.000 description 1
- 125000003143 4-hydroxybenzyl group Chemical group [H]C([*])([H])C1=C([H])C([H])=C(O[H])C([H])=C1[H] 0.000 description 1
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 1
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 1
- 229920000178 Acrylic resin Polymers 0.000 description 1
- 239000004925 Acrylic resin Substances 0.000 description 1
- 235000006667 Aleurites moluccana Nutrition 0.000 description 1
- 244000136475 Aleurites moluccana Species 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- KYLIZBIRMBGUOP-UHFFFAOYSA-N Anetholtrithion Chemical compound C1=CC(OC)=CC=C1C1=CC(=S)SS1 KYLIZBIRMBGUOP-UHFFFAOYSA-N 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 235000002568 Capsicum frutescens Nutrition 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 241000283153 Cetacea Species 0.000 description 1
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 235000001258 Cinchona calisaya Nutrition 0.000 description 1
- 241000699800 Cricetinae Species 0.000 description 1
- LNSXRXFBSDRILE-UHFFFAOYSA-N Cucurbitacin Natural products CC(=O)OC(C)(C)C=CC(=O)C(C)(O)C1C(O)CC2(C)C3CC=C4C(C)(C)C(O)C(O)CC4(C)C3(C)C(=O)CC12C LNSXRXFBSDRILE-UHFFFAOYSA-N 0.000 description 1
- CVKKIVYBGGDJCR-SXDZHWHFSA-N Cucurbitacin B Natural products CC(=O)OC(C)(C)C=CC(=O)[C@@](C)(O)[C@@H]1[C@@H](O)C[C@]2(C)C3=CC[C@@H]4C(C)(C)C(=O)[C@H](O)C[C@@]4(C)[C@@H]3CC(=O)[C@@]12C CVKKIVYBGGDJCR-SXDZHWHFSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- 208000006558 Dental Calculus Diseases 0.000 description 1
- 108010001682 Dextranase Proteins 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 239000001116 FEMA 4028 Substances 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 229920000926 Galactomannan Polymers 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- 235000019487 Hazelnut oil Nutrition 0.000 description 1
- RMFGNMMNUZWCRZ-UHFFFAOYSA-N Humulone Natural products CC(C)CC(=O)C1=C(O)C(O)(CC=C(C)C)C(O)=C(CC=C(C)C)C1=O RMFGNMMNUZWCRZ-UHFFFAOYSA-N 0.000 description 1
- 229920001144 Hydroxy alpha sanshool Polymers 0.000 description 1
- GRSZFWQUAKGDAV-UHFFFAOYSA-N Inosinic acid Natural products OC1C(O)C(COP(O)(O)=O)OC1N1C(NC=NC2=O)=C2N=C1 GRSZFWQUAKGDAV-UHFFFAOYSA-N 0.000 description 1
- IPMYMEWFZKHGAX-UHFFFAOYSA-N Isotheaflavin Natural products OC1CC2=C(O)C=C(O)C=C2OC1C(C1=C2)=CC(O)=C(O)C1=C(O)C(=O)C=C2C1C(O)CC2=C(O)C=C(O)C=C2O1 IPMYMEWFZKHGAX-UHFFFAOYSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 102000010445 Lactoferrin Human genes 0.000 description 1
- 108010063045 Lactoferrin Proteins 0.000 description 1
- 108010023244 Lactoperoxidase Proteins 0.000 description 1
- 102000045576 Lactoperoxidases Human genes 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- VHLJDTBGULNCGF-UHFFFAOYSA-N Limonin Natural products CC1(C)OC2CC(=O)OCC23C4CCC5(C)C(CC(=O)C6OC56C4(C)C(=O)CC13)c7cocc7 VHLJDTBGULNCGF-UHFFFAOYSA-N 0.000 description 1
- OLHLJBVALXTBSQ-UHFFFAOYSA-N Lupulone Natural products CC(C)CC(=O)C1C(=O)C(CC=C(C)C)C(=O)C(CC=C(C)C)(CC=C(C)C)C1=O OLHLJBVALXTBSQ-UHFFFAOYSA-N 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 102000014171 Milk Proteins Human genes 0.000 description 1
- 108010011756 Milk Proteins Proteins 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- ZIKZPLSIAVHITA-UHFFFAOYSA-N Nomilinic acid Natural products CC(=O)OC(CC(O)=O)C1(C)C(C(C)(C)O)CC(=O)C(C23OC2C(=O)O2)(C)C1CCC3(C)C2C=1C=COC=1 ZIKZPLSIAVHITA-UHFFFAOYSA-N 0.000 description 1
- QMGVPVSNSZLJIA-UHFFFAOYSA-N Nux Vomica Natural products C1C2C3C4N(C=5C6=CC=CC=5)C(=O)CC3OCC=C2CN2C1C46CC2 QMGVPVSNSZLJIA-UHFFFAOYSA-N 0.000 description 1
- MAYJEFRPIKEYBL-OASIGRBWSA-N Obacunone Chemical compound C=1([C@@H]2OC(=O)[C@H]3O[C@@]43[C@]3(C)C(=O)C[C@H]5C(C)(C)OC(=O)C=C[C@]5(C)[C@H]3CC[C@]42C)C=COC=1 MAYJEFRPIKEYBL-OASIGRBWSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- QHZLMUACJMDIAE-UHFFFAOYSA-N Palmitic acid monoglyceride Natural products CCCCCCCCCCCCCCCC(=O)OCC(O)CO QHZLMUACJMDIAE-UHFFFAOYSA-N 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 239000004695 Polyether sulfone Substances 0.000 description 1
- 239000004697 Polyetherimide Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- ZONYXWQDUYMKFB-UHFFFAOYSA-N SJ000286395 Natural products O1C2=CC=CC=C2C(=O)CC1C1=CC=CC=C1 ZONYXWQDUYMKFB-UHFFFAOYSA-N 0.000 description 1
- PSKIOIDCXFHNJA-UHFFFAOYSA-N Sanshool Natural products CC=CC=CC=CCCC=CC=CC(=O)NC(C)C PSKIOIDCXFHNJA-UHFFFAOYSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 239000004376 Sucralose Substances 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- UXRMWRBWCAGDQB-UHFFFAOYSA-N Theaflavin Natural products C1=CC(C2C(CC3=C(O)C=C(O)C=C3O2)O)=C(O)C(=O)C2=C1C(C1OC3=CC(O)=CC(O)=C3CC1O)=CC(O)=C2O UXRMWRBWCAGDQB-UHFFFAOYSA-N 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- OQWKEEOHDMUXEO-BQYQJAHWSA-N [6]-Shogaol Chemical compound CCCCC\C=C\C(=O)CCC1=CC=C(O)C(OC)=C1 OQWKEEOHDMUXEO-BQYQJAHWSA-N 0.000 description 1
- 235000010358 acesulfame potassium Nutrition 0.000 description 1
- 229960004998 acesulfame potassium Drugs 0.000 description 1
- 239000000619 acesulfame-K Substances 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- WNLRTRBMVRJNCN-UHFFFAOYSA-L adipate(2-) Chemical compound [O-]C(=O)CCCCC([O-])=O WNLRTRBMVRJNCN-UHFFFAOYSA-L 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 230000002009 allergenic effect Effects 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- FYGDTMLNYKFZSV-DZOUCCHMSA-N alpha-D-Glcp-(1->4)-alpha-D-Glcp-(1->4)-D-Glcp Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](O[C@@H]2[C@H](OC(O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-DZOUCCHMSA-N 0.000 description 1
- SBXYHCVXUCYYJT-UEOYEZOQSA-N alpha-Sanshool Chemical compound C\C=C\C=C\C=C/CC\C=C\C(=O)NCC(C)C SBXYHCVXUCYYJT-UEOYEZOQSA-N 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 229960002684 aminocaproic acid Drugs 0.000 description 1
- 229960005238 anethole trithione Drugs 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 229920003235 aromatic polyamide Polymers 0.000 description 1
- 239000008122 artificial sweetener Substances 0.000 description 1
- 235000021311 artificial sweeteners Nutrition 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- WPVSVIXDXMNGGN-UHFFFAOYSA-N beta-bitter acid Natural products CC(C)CC(=O)C1=C(O)C(CC=C(C)C)(CC=C(C)C)C(=O)C(CC=C(C)C)=C1O WPVSVIXDXMNGGN-UHFFFAOYSA-N 0.000 description 1
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 1
- 235000011175 beta-cyclodextrine Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 229960004853 betadex Drugs 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- QHIWVLPBUQWDMQ-UHFFFAOYSA-N butyl prop-2-enoate;methyl 2-methylprop-2-enoate;prop-2-enoic acid Chemical compound OC(=O)C=C.COC(=O)C(C)=C.CCCCOC(=O)C=C QHIWVLPBUQWDMQ-UHFFFAOYSA-N 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 229960002504 capsaicin Drugs 0.000 description 1
- 235000017663 capsaicin Nutrition 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 239000012185 ceresin wax Substances 0.000 description 1
- 229960000800 cetrimonium bromide Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 150000001904 cucurbitacins Chemical class 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 201000002170 dentin sensitivity Diseases 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- PIGAXYFCLPQWOD-UHFFFAOYSA-N dihydrocucurbitacin I Natural products CC12C(=O)CC3(C)C(C(C)(O)C(=O)CCC(C)(O)C)C(O)CC3(C)C1CC=C1C2C=C(O)C(=O)C1(C)C PIGAXYFCLPQWOD-UHFFFAOYSA-N 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- 238000002036 drum drying Methods 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 210000003989 endothelium vascular Anatomy 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- TVQGDYNRXLTQAP-UHFFFAOYSA-N ethyl heptanoate Chemical compound CCCCCCC(=O)OCC TVQGDYNRXLTQAP-UHFFFAOYSA-N 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 239000010475 evening primrose oil Substances 0.000 description 1
- 229940089020 evening primrose oil Drugs 0.000 description 1
- 229930003949 flavanone Natural products 0.000 description 1
- 235000011981 flavanones Nutrition 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000019264 food flavour enhancer Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- GDSRMADSINPKSL-HSEONFRVSA-N gamma-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO GDSRMADSINPKSL-HSEONFRVSA-N 0.000 description 1
- 229940080345 gamma-cyclodextrin Drugs 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- NLDDIKRKFXEWBK-AWEZNQCLSA-N gingerol Chemical compound CCCCC[C@H](O)CC(=O)CCC1=CC=C(O)C(OC)=C1 NLDDIKRKFXEWBK-AWEZNQCLSA-N 0.000 description 1
- JZLXEKNVCWMYHI-UHFFFAOYSA-N gingerol Natural products CCCCC(O)CC(=O)CCC1=CC=C(O)C(OC)=C1 JZLXEKNVCWMYHI-UHFFFAOYSA-N 0.000 description 1
- 235000002780 gingerol Nutrition 0.000 description 1
- 208000007565 gingivitis Diseases 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 229940068939 glyceryl monolaurate Drugs 0.000 description 1
- GGJRAQULURVTAJ-UHFFFAOYSA-N glyceryl monolinolenate Natural products CCC=CCC=CCC=CCCCCCCCC(=O)OCC(O)CO GGJRAQULURVTAJ-UHFFFAOYSA-N 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 239000008169 grapeseed oil Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- RQFCJASXJCIDSX-UUOKFMHZSA-N guanosine 5'-monophosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O RQFCJASXJCIDSX-UUOKFMHZSA-N 0.000 description 1
- 235000013928 guanylic acid Nutrition 0.000 description 1
- 239000004226 guanylic acid Substances 0.000 description 1
- 230000003648 hair appearance Effects 0.000 description 1
- 239000010468 hazelnut oil Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- 238000007602 hot air drying Methods 0.000 description 1
- VMSLCPKYRPDHLN-NRFANRHFSA-N humulone Chemical compound CC(C)CC(=O)C1=C(O)C(CC=C(C)C)=C(O)[C@@](O)(CC=C(C)C)C1=O VMSLCPKYRPDHLN-NRFANRHFSA-N 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 235000013902 inosinic acid Nutrition 0.000 description 1
- 239000004245 inosinic acid Substances 0.000 description 1
- 229940028843 inosinic acid Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 150000002540 isothiocyanates Chemical class 0.000 description 1
- 239000012182 japan wax Substances 0.000 description 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940078795 lactoferrin Drugs 0.000 description 1
- 235000021242 lactoferrin Nutrition 0.000 description 1
- 229940057428 lactoperoxidase Drugs 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 229940033355 lauric acid Drugs 0.000 description 1
- KBDSLGBFQAGHBE-MSGMIQHVSA-N limonin Chemical compound C=1([C@H]2[C@]3(C)CC[C@H]4[C@@]([C@@]53O[C@@H]5C(=O)O2)(C)C(=O)C[C@@H]2[C@]34COC(=O)C[C@@H]3OC2(C)C)C=COC=1 KBDSLGBFQAGHBE-MSGMIQHVSA-N 0.000 description 1
- 150000002630 limonoids Chemical class 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- LSDULPZJLTZEFD-UHFFFAOYSA-N lupulone Chemical compound CC(C)CC(=O)C1=C(O)C(CC=C(C)C)=C(O)C(CC=C(C)C)(CC=C(C)C)C1=O LSDULPZJLTZEFD-UHFFFAOYSA-N 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 229960002337 magnesium chloride Drugs 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 235000021239 milk protein Nutrition 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- RZRNAYUHWVFMIP-UHFFFAOYSA-N monoelaidin Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-UHFFFAOYSA-N 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 235000021096 natural sweeteners Nutrition 0.000 description 1
- ARGKVCXINMKCAZ-UZRWAPQLSA-N neohesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O[C@H]3[C@@H]([C@H](O)[C@@H](O)[C@H](C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UZRWAPQLSA-N 0.000 description 1
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- KPDOJFFZKAUIOE-WNGDLQANSA-N nomilin Chemical compound C=1([C@H]2[C@]3(C)CC[C@H]4[C@@]([C@@]53O[C@@H]5C(=O)O2)(C)C(=O)C[C@H]2C(C)(C)OC(=O)C[C@@H]([C@]42C)OC(=O)C)C=COC=1 KPDOJFFZKAUIOE-WNGDLQANSA-N 0.000 description 1
- KPDOJFFZKAUIOE-HPFWCIFASA-N nomilin Natural products O=C(O[C@H]1[C@@]2(C)[C@@H](C(C)(C)OC(=O)C1)CC(=O)[C@]1(C)[C@@H]2CC[C@@]2(C)[C@H](c3cocc3)OC(=O)[C@@H]3O[C@@]123)C KPDOJFFZKAUIOE-HPFWCIFASA-N 0.000 description 1
- 235000019488 nut oil Nutrition 0.000 description 1
- VSLDMVSILHVDSR-UHFFFAOYSA-N obacunone Natural products CC1(C)OC(=O)C=CC2(C)C1CC(=O)C3(C)C2CCC4(C)C(OC(=O)C5OC345)c6occc6 VSLDMVSILHVDSR-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 210000003101 oviduct Anatomy 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 229940098695 palmitic acid Drugs 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 235000019809 paraffin wax Nutrition 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 201000001245 periodontitis Diseases 0.000 description 1
- 210000004303 peritoneum Anatomy 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- RNAICSBVACLLGM-GNAZCLTHSA-N pilocarpine hydrochloride Chemical compound Cl.C1OC(=O)[C@@H](CC)[C@H]1CC1=CN=CN1C RNAICSBVACLLGM-GNAZCLTHSA-N 0.000 description 1
- 229960002139 pilocarpine hydrochloride Drugs 0.000 description 1
- WVWHRXVVAYXKDE-UHFFFAOYSA-N piperine Natural products O=C(C=CC=Cc1ccc2OCOc2c1)C3CCCCN3 WVWHRXVVAYXKDE-UHFFFAOYSA-N 0.000 description 1
- MXXWOMGUGJBKIW-YPCIICBESA-N piperine Chemical compound C=1C=C2OCOC2=CC=1/C=C/C=C/C(=O)N1CCCCC1 MXXWOMGUGJBKIW-YPCIICBESA-N 0.000 description 1
- 229940075559 piperine Drugs 0.000 description 1
- 235000019100 piperine Nutrition 0.000 description 1
- 210000004224 pleura Anatomy 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 229920002492 poly(sulfone) Polymers 0.000 description 1
- 229920006350 polyacrylonitrile resin Polymers 0.000 description 1
- 229920006122 polyamide resin Polymers 0.000 description 1
- 229920005668 polycarbonate resin Polymers 0.000 description 1
- 239000004431 polycarbonate resin Substances 0.000 description 1
- 229920001225 polyester resin Polymers 0.000 description 1
- 239000004645 polyester resin Substances 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920006393 polyether sulfone Polymers 0.000 description 1
- 229920001601 polyetherimide Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920013716 polyethylene resin Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920005990 polystyrene resin Polymers 0.000 description 1
- 229920005749 polyurethane resin Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 229960000948 quinine Drugs 0.000 description 1
- GGJRAQULURVTAJ-PDBXOOCHSA-N rac-1-alpha-linolenoylglycerol Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(=O)OCC(O)CO GGJRAQULURVTAJ-PDBXOOCHSA-N 0.000 description 1
- DCBSHORRWZKAKO-UHFFFAOYSA-N rac-1-monomyristoylglycerol Chemical compound CCCCCCCCCCCCCC(=O)OCC(O)CO DCBSHORRWZKAKO-UHFFFAOYSA-N 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- WBHHMMIMDMUBKC-XLNAKTSKSA-N ricinelaidic acid Chemical class CCCCCC[C@@H](O)C\C=C\CCCCCCCC(O)=O WBHHMMIMDMUBKC-XLNAKTSKSA-N 0.000 description 1
- 239000010667 rosehip oil Substances 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 235000015067 sauces Nutrition 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 229920002050 silicone resin Polymers 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 1
- 239000011775 sodium fluoride Substances 0.000 description 1
- 235000013024 sodium fluoride Nutrition 0.000 description 1
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 1
- 229960004711 sodium monofluorophosphate Drugs 0.000 description 1
- 229940048086 sodium pyrophosphate Drugs 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 208000003265 stomatitis Diseases 0.000 description 1
- 235000019408 sucralose Nutrition 0.000 description 1
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 230000036413 temperature sense Effects 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 235000019818 tetrasodium diphosphate Nutrition 0.000 description 1
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 1
- 235000010436 thaumatin Nutrition 0.000 description 1
- 239000000892 thaumatin Substances 0.000 description 1
- 235000014620 theaflavin Nutrition 0.000 description 1
- IPMYMEWFZKHGAX-ZKSIBHASSA-N theaflavin Chemical compound C1=C2C([C@H]3OC4=CC(O)=CC(O)=C4C[C@H]3O)=CC(O)=C(O)C2=C(O)C(=O)C=C1[C@@H]1[C@H](O)CC2=C(O)C=C(O)C=C2O1 IPMYMEWFZKHGAX-ZKSIBHASSA-N 0.000 description 1
- 229940026509 theaflavin Drugs 0.000 description 1
- 235000008118 thearubigins Nutrition 0.000 description 1
- 229960004559 theobromine Drugs 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- 229940034610 toothpaste Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- VXYADVIJALMOEQ-UHFFFAOYSA-K tris(lactato)aluminium Chemical compound CC(O)C(=O)O[Al](OC(=O)C(C)O)OC(=O)C(C)O VXYADVIJALMOEQ-UHFFFAOYSA-K 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 210000005239 tubule Anatomy 0.000 description 1
- 210000000626 ureter Anatomy 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000007762 w/o emulsion Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- 239000003871 white petrolatum Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Abstract
【課題】医薬、化粧品、飲食品等の分野において有効成分の効果を増強、及び/又は長く維持することを可能とする滞留剤を提供する。
【解決手段】水、疎水性物質、サイクロデキストリン、及び増粘多糖類を含む水中油型エマルジョンを含む、有効成分を滞留させるために用いられる滞留剤とする。好ましくは、疎水性物質が、油脂、疎水性ワックス、及び疎水性樹脂からなる群、増粘多糖類が、カルボキシメチルセルロース、キサンタンガム、ローカストビーンガム、グアーガム、グルコマンナン、κ-カラギーナン、ι-カラギーナン、λ-カラギーナン、タマリンドガム、ジェランガム、アラビアガム、ペクチン、リン酸架橋でんぷん、ヒドロキシプロピルでんぷん、ヒドロキシプロピル化リン酸架橋でんぷん、トラガントガム、ヒドロキシプロピルセルロース、メチルセロース、ヒドロキシプロピルメチルセルロース等からなる群よりそれぞれ選択される一種以上である。
【選択図】なしThe present invention provides a retention agent that can enhance and/or prolong the effects of active ingredients in the fields of medicine, cosmetics, food and beverages, etc.
[Solution] A retention agent used for retaining an active ingredient includes an oil-in-water emulsion containing water, a hydrophobic substance, cyclodextrin, and a thickening polysaccharide. Preferably, the hydrophobic substance is one or more selected from the group consisting of fats and oils, hydrophobic waxes, and hydrophobic resins, and the thickening polysaccharide is one or more selected from the group consisting of carboxymethylcellulose, xanthan gum, locust bean gum, guar gum, glucomannan, κ-carrageenan, ι-carrageenan, λ-carrageenan, tamarind gum, gellan gum, gum arabic, pectin, phosphate cross-linked starch, hydroxypropyl starch, hydroxypropylated phosphate cross-linked starch, tragacanth gum, hydroxypropylcellulose, methylcellulose, hydroxypropylmethylcellulose, etc.
[Selection diagram] None
Description
本発明は、水、疎水性物質、サイクロデキストリン、及び、増粘多糖類を含む水中油型エマルジョンを含む、有効成分を滞留させるために用いられる滞留剤に関するものである。 The present invention relates to a retention agent used to retain an active ingredient, comprising an oil-in-water emulsion containing water, a hydrophobic substance, a cyclodextrin, and a thickening polysaccharide.
今日、油脂、水、サイクロデキストリン、及び水溶性ゲル化剤を含んでなる乳化組成物が、医薬、化粧品、飲食品等の様々な分野で広く利用されている。 Today, emulsion compositions containing fats and oils, water, cyclodextrin, and water-soluble gelling agents are widely used in a variety of fields, including medicine, cosmetics, and food and beverages.
特許文献1には、水、油性成分、αサイクロデキストリン、及びゲル形成成分として寒天、低強度寒天、ガラクトマンナン又はグルコマンナンとキサンタンガムの併用、カラギーナン、ファーセレラン、ジェランガム、ネーティブ型ジェランガムのいずれか1以上を含有する乳化組成物が開示され、これを使用した医薬品、化粧品、化成品が開示されている。 Patent Document 1 discloses an emulsion composition containing water, an oily component, α-cyclodextrin, and one or more of agar, low-strength agar, a combination of galactomannan or glucomannan with xanthan gum, carrageenan, furcellaran, gellan gum, and native gellan gum as gel-forming components, and also discloses pharmaceuticals, cosmetics, and chemical products that use the emulsion composition.
特許文献2には、油脂、蛋白加水分解物、水、サイクロデキストリン等を含有することを特徴とする乳化組成物が開示され、また、安定剤としてキサンタンガム、グアーガム、アラビアガムCMC、カラギーナン、ローカストビーンガム等のガム類を用いてもよいことが開示されている。 Patent Document 2 discloses an emulsion composition that contains fats and oils, hydrolyzed proteins, water, cyclodextrin, and the like, and also discloses that gums such as xanthan gum, guar gum, gum arabic CMC, carrageenan, and locust bean gum may be used as stabilizers.
特許文献3には、ペクチン、トラガントガム、ゼラチン、カゼイン、アルギン酸ナトリウム、ヒドロキシプロピルセルロース、ヒドロキシエチルセルロース、ヒドロキシプロピルメチルセルロース、メチルセルロース、ポリアクリル酸ナトリウム、カルボキシビニルポリマーといった水溶性高分子化合物を溶解した水性原料と化粧料用油性原料を混和し、サイクロデキストリンを加えて乳化させてなる乳化化粧料が開示されている。 Patent Document 3 discloses an emulsified cosmetic product obtained by mixing an aqueous raw material in which a water-soluble polymer compound such as pectin, gum tragacanth, gelatin, casein, sodium alginate, hydroxypropyl cellulose, hydroxyethyl cellulose, hydroxypropyl methyl cellulose, methyl cellulose, sodium polyacrylate, or carboxyvinyl polymer is dissolved, with an oil-based raw material for cosmetics, and emulsifying the mixture by adding cyclodextrin.
特許文献4には、水、油脂及びサイクロデキストリン、ならびに、カルボキシメチルセルロース(CMC)、キサンタンガム、ローカストビーンガム、グアーガム、グルコマンナン、κ-カラギーナン、ι-カラギーナン、λ-カラギーナン、タマリンドガム、ジェランガムからなる群から選択される少なくとも一つの水溶性ゲル化剤を含む、皮膚用乳化組成物が開示されている。 Patent Document 4 discloses an emulsion composition for skin that contains water, fats and oils, cyclodextrin, and at least one water-soluble gelling agent selected from the group consisting of carboxymethylcellulose (CMC), xanthan gum, locust bean gum, guar gum, glucomannan, κ-carrageenan, ι-carrageenan, λ-carrageenan, tamarind gum, and gellan gum.
非特許文献1には、大豆油とサイクロデキストリン水溶液の1:1容積比試料を乳化させてなる水中油滴型のエマルションに、乳化安定剤としてキサンタンガムとトラガントガムをそれぞれ添加したところ乳化安定性が増したことが記載されている。 Non-Patent Document 1 describes that the emulsion stability was increased when xanthan gum and tragacanth gum were added as emulsion stabilizers to an oil-in-water emulsion made by emulsifying a sample of soybean oil and an aqueous cyclodextrin solution in a 1:1 volume ratio.
医薬、化粧品、飲食品等の分野においては従前より、対象の負担軽減や消費者の健康志向の高まり等の理由から、有効成分である薬剤や味質の成分等の含有量を低減することが切望されており、そのため有効成分の効果を増強、及び/又は長く維持することを可能とする手段が求められていた。そこで、本発明は、有効成分の効果を増強、及び/又は長く維持することを可能とする新たな手段を提供することを目的とする。 In the fields of medicine, cosmetics, food and beverages, etc., there has long been a desire to reduce the content of active ingredients such as drugs and taste components for reasons such as reducing the burden on patients and increasing health consciousness among consumers, and therefore there has been a demand for means that make it possible to enhance and/or prolong the effects of active ingredients. Therefore, the present invention aims to provide a new means that makes it possible to enhance and/or prolong the effects of active ingredients.
本発明者らは、上記課題を解決すべく鋭意検討した結果、疎水性物質、水、サイクロデキストリン、及び、増粘多糖類を配合してなる水中油型エマルジョンが、動物の組織に付着して、そこで有効成分を保持し、及び/又は有効成分を吸収・吸着して保持することによって、滞留させることができ、当該組織において有効成分による効果を増強、及び/又は長く維持できることを見出した。 The inventors of the present invention have conducted extensive research to solve the above problems and have found that an oil-in-water emulsion containing a hydrophobic substance, water, cyclodextrin, and a thickening polysaccharide can adhere to animal tissue and retain the active ingredient there, and/or absorb, adsorb, and retain the active ingredient, thereby allowing it to remain there, thereby enhancing and/or prolonging the effect of the active ingredient in the tissue.
本発明は、これらの新規知見に基づくものであり、以下の発明を包含する。
[1] 水、疎水性物質、サイクロデキストリン、及び、増粘多糖類を含む水中油型エマルジョンを含む、有効成分を滞留させるために用いられる滞留剤。
[2] 疎水性物質が、油脂、疎水性ワックス、及び疎水性樹脂からなる群より選択される一種以上である、[1]の滞留剤。
[3] 増粘多糖類が、カルボキシメチルセルロース(CMC)、キサンタンガム、ローカストビーンガム、グアーガム、グルコマンナン、κ-カラギーナン、ι-カラギーナン、λ-カラギーナン、タマリンドガム、ジェランガム、アラビアガム、ペクチン、リン酸架橋でんぷん、ヒドロキシプロピルでんぷん、ヒドロキシプロピル化リン酸架橋でんぷん、トラガントガム、ヒドロキシプロピルセルロース、メチルセロース、ヒドロキシプロピルメチルセルロース、及び、ヒドロキシエチルセルロースからなる群より選択される一種以上である、[1]又は[2]の滞留剤。
[4] 飲食品に添加して用いられる、[1]~[3]のいずれかの滞留剤。
[5] 医薬品に添加して用いられる、[1]~[3]のいずれかの滞留剤。
[6] 化粧品に添加して用いられる、[1]~[3]のいずれかの滞留剤。
[7] 水、疎水性物質、サイクロデキストリン、及び、増粘多糖類を混合して水中油型エマルジョンを形成する工程を含む、有効成分を滞留させるために用いられる滞留剤の製造方法。
[8] 水、疎水性物質、サイクロデキストリン、及び、増粘多糖類を含む水中油型エマルジョンを含む、有効成分を滞留させるために用いられる滞留剤を、その疎水性物質の量にして0.5質量%~55質量%含んでなる、飲食品。
[9] 水、疎水性物質、サイクロデキストリン、及び、増粘多糖類を含む水中油型エマルジョンを含む、有効成分を滞留させるために用いられる滞留剤を、その疎水性物質の量にして0.5質量%~55質量%含んでなる、医薬品。
[10] 水、疎水性物質、サイクロデキストリン、及び、増粘多糖類を含む水中油型エマルジョンを含む、有効成分を滞留させるために用いられる滞留剤を、その疎水性物質の量にして0.5質量%~55質量%含んでなる、化粧品。
[11] 有効成分を滞留させるために用いられる滞留剤の製造方法における、水、疎水性物質、サイクロデキストリン、及び、増粘多糖類を含む水中油型エマルジョンの使用。
本明細書は本願の優先権の基礎である2022年12月28日に出願された日本国特許出願2022-211335号の明細書等に記載される内容を包含する。
本明細書で引用した全ての刊行物、特許および特許出願をそのまま参考として本明細書にとりいれるものとする。
The present invention is based on these new findings and includes the following inventions.
[1] A retention agent used to retain an active ingredient, comprising an oil-in-water emulsion containing water, a hydrophobic substance, a cyclodextrin, and a thickening polysaccharide.
[2] The retention agent according to [1], wherein the hydrophobic substance is one or more selected from the group consisting of oils and fats, hydrophobic waxes, and hydrophobic resins.
[3] The retention agent according to [1] or [2], wherein the thickening polysaccharide is one or more selected from the group consisting of carboxymethylcellulose (CMC), xanthan gum, locust bean gum, guar gum, glucomannan, κ-carrageenan, ι-carrageenan, λ-carrageenan, tamarind gum, gellan gum, gum arabic, pectin, phosphate cross-linked starch, hydroxypropyl starch, hydroxypropylated phosphate cross-linked starch, tragacanth gum, hydroxypropyl cellulose, methyl cellulose, hydroxypropyl methyl cellulose, and hydroxyethyl cellulose.
[4] A retention agent according to any one of [1] to [3], which is added to a food or drink.
[5] A retention agent according to any one of [1] to [3], which is added to a pharmaceutical.
[6] A retention agent according to any one of [1] to [3], which is added to a cosmetic product.
[7] A method for producing a retention agent used to retain an active ingredient, comprising the step of mixing water, a hydrophobic substance, a cyclodextrin, and a thickening polysaccharide to form an oil-in-water emulsion.
[8] A food or beverage comprising a retention agent used to retain an active ingredient, the retention agent comprising an oil-in-water emulsion containing water, a hydrophobic substance, cyclodextrin, and a thickening polysaccharide, in an amount of 0.5% by mass to 55% by mass in terms of the amount of the hydrophobic substance.
[9] A pharmaceutical comprising a retention agent used to retain an active ingredient, the retention agent comprising an oil-in-water emulsion containing water, a hydrophobic substance, cyclodextrin, and a thickening polysaccharide, in an amount of 0.5% by mass to 55% by mass in terms of the amount of the hydrophobic substance.
[10] A cosmetic comprising a retention agent used to retain an active ingredient, the retention agent comprising an oil-in-water emulsion containing water, a hydrophobic substance, cyclodextrin, and a thickening polysaccharide, in an amount of 0.5% by mass to 55% by mass in terms of the amount of the hydrophobic substance.
[11] Use of an oil-in-water emulsion containing water, a hydrophobic substance, a cyclodextrin, and a thickening polysaccharide in a method for producing a retention agent used for retaining an active ingredient.
This specification includes the contents described in the specification of Japanese Patent Application No. 2022-211335, filed on December 28, 2022, which is the priority basis of this application.
All publications, patents, and patent applications cited herein are hereby incorporated by reference in their entirety.
本発明によれば、動物の組織上に、有効成分を滞留させることができ、有効成分による効果を増強、及び/又は長く維持することを可能とする、有効成分の滞留剤を提供することができる。 The present invention provides an active ingredient retention agent that can retain an active ingredient on the tissues of an animal, thereby enhancing and/or prolonging the effects of the active ingredient.
1.水中油型エマルジョン
本発明における水中油型エマルジョンは、水、疎水性物質、サイクロデキストリン、及び、増粘多糖類を含むものである。
1. Oil-in-water emulsion The oil-in-water emulsion of the present invention contains water, a hydrophobic substance, a cyclodextrin, and a thickening polysaccharide.
本発明において「疎水性物質」とは、水に不溶性であり、水と下記に詳述する、サイクロデキストリン、及び、増粘多糖類と共に、水中油型エマルジョンを形成することが可能な物質であればよく、特に限定されるものではないが、好ましくは、油脂、疎水性ワックス、疎水性樹脂等が挙げられる。疎水性物質はいずれかの物質を単独で用いてもよいし、あるいは異なる種類の疎水性物質を組み合わせて用いてもよい。例えば、疎水性物質は、油脂、疎水性ワックス、及び疎水性樹脂からなる群より選択される一種以上の物質を用いることができ、本発明の滞留剤の利用態様に応じて、適当なものを選択して用いることができる。 In the present invention, the "hydrophobic substance" refers to a substance that is insoluble in water and capable of forming an oil-in-water emulsion together with water and cyclodextrin and thickening polysaccharides, which will be described in detail below. Although there is no particular limitation, preferred examples include fats and oils, hydrophobic waxes, and hydrophobic resins. The hydrophobic substance may be any substance used alone, or different types of hydrophobic substances may be used in combination. For example, the hydrophobic substance may be one or more substances selected from the group consisting of fats and oils, hydrophobic waxes, and hydrophobic resins, and an appropriate substance may be selected and used depending on the usage mode of the retention agent of the present invention.
本発明において「水中油型エマルジョン」とは、水の中に疎水性物質が分散してなる乳化組成物を意味し、サイクロデキストリン、及び、増粘多糖類はこの乳化状態の形成や安定性に寄与する。 In the present invention, "oil-in-water emulsion" refers to an emulsion composition in which a hydrophobic substance is dispersed in water, and cyclodextrin and thickening polysaccharides contribute to the formation and stability of this emulsion.
本発明において「油脂」とは、水中油型エマルジョンの形成において一般的に使用される油脂を利用することができ、極性及び非極性のいずれも使用することができる。このような油脂としては、例えば、植物由来の油脂(例えば、キャノーラ油、菜種白絞油、大豆油、コーン油、綿実油、落花生油、ゴマ油、米油、米糠油、ツバキ油、ベニバナ油、オリーブ油、アマニ油、シソ油、エゴマ油、ヒマワリ油、パーム油、茶油、ヤシ油、アボガド油、ククイナッツ油、グレープシード油、ココアバター、ココナッツ油、小麦胚芽油、アーモンド油、月見草油、ひまし油、ヘーゼルナッツ油、マカダミアナッツ油、ローズヒップ油、ブドウ油、カカオ油、ホホバ油、パーム核油、等)、イソステアリルアルコール、カプリルアルコール、ラウリルアルコール、ステアリルアルコール、2-オクタデシルアルコール、ミリスチルアルコール、セチルアルコール、フィトステロール、コレステロール、ステアリン酸、イソステアリン酸、カプリン酸、ラノリン酸、ラウリン酸、ミリスチン酸、パルミチン酸、ベヘニン酸、リノール酸、リノレン酸、モノステアリン酸グリセリル、モノパルミチン酸グリセリル、モノベヘニン酸グリセリル、モノミリスチン酸グリセリル、モノラウリン酸グリセリル、モノラノリン酸グリセリル、モノリノ-ル酸グリセリル、モノリノレン酸グリセリル、モノオレイン酸グリセリル、トリイソステアリン酸グリセリン、イソプロピルミリステート、グリセロールトリ-2-ヘプチルウンデカノエート、グリセロールトリ-2-エチルヘキサノエート、2-ヘプチルウンデシルパルミテート、ジ-2-ヘプチルウンデシルアジペート、セチルイソオクタノエート、トリメチロールプロパン-2-トリメチロールヘプチルウンデカノエート、プロパン-2-エチルヘキサノエート、ペンタエリスリトール-2-ヘプチルウンデカノエート、ペンタエリスリトール-2-エチルヘキサノエート、コレステロールイソステアレート、ジエチルフタレート、ジブチルフタレート等の合成エステル油、牛脂、豚油、ラノリン、スクワレン、スクワラン等の動物由来の油脂、シリコーン油等が挙げられるが、これらに限定はされない。本発明において利用される油脂としては、少なくとも常温において液体の状態のものが好ましく、ならびに、安全性の高い動物由来又は植物由来の油脂が好ましく、食経験があり安全性の高い食用植物油が特に好ましい。油脂はいずれか単独で用いてもよいし、異なる油脂を組み合わせて用いてもよく、本発明の滞留剤の利用態様に応じて、適当なものを選択して用いることができる。なお、本明細書において「常温」とは、5~35℃、好ましくは15~30℃を意味する。 In the present invention, the term "oils and fats" refers to oils and fats that are generally used in the formation of oil-in-water emulsions, and both polar and non-polar oils and fats can be used. Examples of such oils and fats include vegetable oils and fats (e.g., canola oil, rapeseed oil, soybean oil, corn oil, cottonseed oil, peanut oil, sesame oil, rice oil, rice bran oil, camellia oil, safflower oil, olive oil, linseed oil, perilla oil, perilla oil, sunflower oil, palm oil, tea oil, coconut oil, avocado oil, kukui nut oil, grapeseed oil, cocoa butter, coconut oil, wheat germ oil, almond oil, evening primrose oil, castor oil, hazelnut oil, macadamia nut oil, rosehip oil, grape oil, etc.). , cocoa oil, jojoba oil, palm kernel oil, etc.), isostearyl alcohol, capryl alcohol, lauryl alcohol, stearyl alcohol, 2-octadecyl alcohol, myristyl alcohol, cetyl alcohol, phytosterol, cholesterol, stearic acid, isostearic acid, capric acid, lanolinic acid, lauric acid, myristic acid, palmitic acid, behenic acid, linoleic acid, linolenic acid, glyceryl monostearate, glyceryl monopalmitate, mono Glyceryl behenate, glyceryl monomyristate, glyceryl monolaurate, glyceryl monolanolate, glyceryl monolinoleate, glyceryl monolinolenate, glyceryl monooleate, glyceryl triisostearate, isopropyl myristate, glycerol tri-2-heptylundecanoate, glycerol tri-2-ethylhexanoate, 2-heptylundecyl palmitate, di-2-heptylundecyl adipate, cetyl isooctadecyl Examples of the oils and fats used in the present invention include, but are not limited to, synthetic ester oils such as tallow, lard, lanolin, squalene, and squalane, silicone oils, and the like, but are not limited to these. The oils and fats used in the present invention are preferably those that are in a liquid state at least at room temperature, and are preferably oils and fats derived from animals or plants that are highly safe, and are particularly preferably edible vegetable oils that have been used in food and are highly safe. The oils and fats may be used alone or in combination with different oils and fats, and the appropriate one may be selected and used depending on the usage mode of the retention agent of the present invention. In this specification, "room temperature" means 5 to 35°C, preferably 15 to 30°C.
本発明において「疎水性ワックス」とは、動植物や石油若しくは鉱物由来の天然疎水性ワックス、合成の疎水性ワックスが挙げられ、80℃以下の融点を有するものを使用することができ、少なくとも常温において液体の状態のものが好ましい。このような疎水性ワックスとしては、例えば、ミツロウ、鯨ロウ、羊毛ロウ、モクロウ、ロジン(松脂)、キャンデリラロウ、カルナバロウ、カカオ脂、パラフィンワックス、マイクロクリスタリンワックス、セレシンワックス、ワセリンワックス、オゾケナイトワックス、ポリエチレンワックス、酸化ポリエチレンワックス、フィッシャートロプシュワックス、アルコール変性ワックス、マレイン酸変性酸化ポリエチレンワックス、アミドワックス、等が挙げられるが、これらに限定はされない。本発明において利用される疎水性ワックスとしては、安全性の高い動物由来又は植物由来の疎水性ワックスが特に好ましい。疎水性ワックスはいずれか単独で用いてもよいし、異なる疎水性ワックスを組み合わせて用いてもよく、本発明の滞留剤の利用態様に応じて、適当なものを選択して用いることができる。 In the present invention, the term "hydrophobic wax" refers to natural hydrophobic wax derived from animals, plants, petroleum or minerals, and synthetic hydrophobic waxes. Waxes having a melting point of 80°C or less can be used, and those that are in a liquid state at least at room temperature are preferred. Examples of such hydrophobic waxes include beeswax, whale wax, wool wax, Japan wax, rosin (pine resin), candelilla wax, carnauba wax, cocoa butter, paraffin wax, microcrystalline wax, ceresin wax, petrolatum wax, ozokenit wax, polyethylene wax, oxidized polyethylene wax, Fischer-Tropsch wax, alcohol-modified wax, maleic acid-modified oxidized polyethylene wax, amide wax, and the like, but are not limited thereto. As the hydrophobic wax used in the present invention, highly safe hydrophobic waxes derived from animals or plants are particularly preferred. Any of the hydrophobic waxes may be used alone, or different hydrophobic waxes may be used in combination. Depending on the mode of use of the retention agent of the present invention, an appropriate wax may be selected and used.
本発明において「疎水性樹脂」とは、親水性基を有さないか又はその含有量が小さな樹脂であり、水等の極性溶媒に溶解しない樹脂を指し、本発明においては少なくとも常温において液体の状態のものを好適に用いることができる。このような疎水性樹脂としては、例えば、シリコーン樹脂(親水化されていないもの)、ポリウレタン樹脂、フッ素含有樹脂、ポリエチレン樹脂、ポリプロピレン樹脂、ポリエステル樹脂、アクリル樹脂、ポリスチレン樹脂、ポリカーボネート樹脂、ポリ塩化ビニル樹脂、ポリサルホン樹脂、ポリエーテルサルホン樹脂、ポリアラミド樹脂、ポリアミド樹脂、ポリエーテル樹脂、ポリアクリロニトリル樹脂、ポリエーテルイミド樹脂、ならびにこれらのポリマーの共重合体等が挙げられるが、これらに限定はされない。本発明において利用される疎水性樹脂としては、生体適合性や生体親和性有することが確認された安全性の高いものが特に好ましい。疎水性樹脂はいずれか単独で用いてもよいし、異なる疎水性樹脂を組み合わせて用いてもよく、本発明の滞留剤の利用態様に応じて、適当なものを選択して用いることができる。 In the present invention, the term "hydrophobic resin" refers to a resin that does not have hydrophilic groups or has a small content of hydrophilic groups and does not dissolve in polar solvents such as water. In the present invention, a resin that is in a liquid state at least at room temperature can be preferably used. Examples of such hydrophobic resins include silicone resins (not hydrophilized), polyurethane resins, fluorine-containing resins, polyethylene resins, polypropylene resins, polyester resins, acrylic resins, polystyrene resins, polycarbonate resins, polyvinyl chloride resins, polysulfone resins, polyethersulfone resins, polyaramid resins, polyamide resins, polyether resins, polyacrylonitrile resins, polyetherimide resins, and copolymers of these polymers, but are not limited to these. As the hydrophobic resin used in the present invention, a highly safe resin that has been confirmed to have biocompatibility and bioaffinity is particularly preferable. Any hydrophobic resin may be used alone, or different hydrophobic resins may be used in combination, and an appropriate one can be selected and used depending on the usage mode of the retention agent of the present invention.
本発明において「疎水性物質」とは、好ましくは油脂及び疎水性ワックスであり、特に好ましくは油脂である。 In the present invention, the "hydrophobic substance" is preferably fats and oils and hydrophobic waxes, and is particularly preferably fats and oils.
本発明の水中油型エマルジョンには、疎水性物質を任意の量で含むことができ、例えば、1質量%以上、3質量%以上、5質量%以上、又は7質量%以上の量で含み、その上限は特に限定されるものではないが、例えば、50質量%以下、40質量%以下、30質量%以下、20質量%以下、又は10質量%以下とすることができる。本発明の水中油型エマルジョンにおける疎水性物質の量の範囲は前記下限及び上限の数値よりそれぞれ選択される2つの数値を用いて表すことができ、例えば、本発明の水中油型エマルジョンには疎水性物質を、1質量%~50質量%、1質量%~30質量%、又は1質量%~20質量%、又は1質量%~10質量%、好ましくは、5質量%~10質量%、又は7質量%~10質量%の範囲より適宜選択される量にて含めることができる。疎水性物質の量が1質量%よりも少ないと乳化が不十分となる場合があり、一方、疎水性物質の量が50質量%よりも多いとべとつきやぬるつき等が強く感じられる場合があり、いずれにおいても目的の用途における利用形態において、有効成分を滞留させることができない場合や、所望の使用感を得ることができない場合がある。 The oil-in-water emulsion of the present invention may contain any amount of hydrophobic substance, for example, 1% by mass or more, 3% by mass or more, 5% by mass or more, or 7% by mass or more, and the upper limit is not particularly limited, but may be, for example, 50% by mass or less, 40% by mass or less, 30% by mass or less, 20% by mass or less, or 10% by mass or less. The range of the amount of hydrophobic substance in the oil-in-water emulsion of the present invention may be expressed using two numerical values selected from the lower and upper numerical values, respectively, and for example, the oil-in-water emulsion of the present invention may contain the hydrophobic substance in an amount appropriately selected from the range of 1% by mass to 50% by mass, 1% by mass to 30% by mass, 1% by mass to 20% by mass, or 1% by mass to 10% by mass, preferably 5% by mass to 10% by mass, or 7% by mass to 10% by mass. If the amount of hydrophobic substance is less than 1% by mass, emulsification may be insufficient, while if the amount of hydrophobic substance is more than 50% by mass, the product may feel sticky or slimy. In either case, the active ingredient may not be retained in the intended form of use, or the desired feel may not be obtained.
なお、本明細書中、本発明の水中油型エマルジョンに含まれる各成分の量の記載は、当該水中油型エマルジョンの全質量を100質量%とする、質量%の量にて示す。 In this specification, the amount of each component contained in the oil-in-water emulsion of the present invention is expressed in terms of mass %, with the total mass of the oil-in-water emulsion being 100 mass %.
本発明の水中油型エマルジョンにおいて、水は疎水性物質を乳化してサイクロデキストリン及び増粘多糖類と共に水中油型エマルジョン形成することが可能な任意の量で含むことができる。例えば、本発明の水中油型エマルジョンは水を、15質量%以上、20質量%以上、30質量%以上、40質量%以上、45質量%以上、50質量%以上、60質量%以上、又は70質量%以上の量で含み、その上限は特に限定されるものではないが、例えば、90質量%以下、又は85質量%以下とすることができる。本発明の水中油型エマルジョンにおける水の量の範囲は前記下限及び上限の数値よりそれぞれ選択される2つの数値を用いて表すことができ、例えば、本発明の水中油型エマルジョンには水を、15質量%~90質量%、45質量%~90質量%、又は70質量%~85質量%の範囲より適宜選択される量にて含めることができる。本発明の水中油型エマルジョンに含まれる水の量は、体積比にして疎水性物質よりも多く含まれることが好ましく、例えば疎水性物質と水の含有量は体積比にして(疎水性物質:水)1:1を超える量、例えば、1:2以上、1:3以上、1:4以上、1:5以上、1:6以上、1:10以上、1:15以上、又は1:20以上、とすることができ、水の量の上限は特に限定されないが、1:90以下、1:80以下、1:70以下、1:60以下、又は1:50以下とすることができる。本発明の水中油型エマルジョンに含まれる水と疎水性物質の量を上記範囲に調節することによって、べとつきやぬるつき等を抑えることができる。 In the oil-in-water emulsion of the present invention, water can be contained in any amount that can emulsify the hydrophobic substance and form an oil-in-water emulsion together with the cyclodextrin and thickening polysaccharide. For example, the oil-in-water emulsion of the present invention contains water in an amount of 15% by mass or more, 20% by mass or more, 30% by mass or more, 40% by mass or more, 45% by mass or more, 50% by mass or more, 60% by mass or more, or 70% by mass or more, and the upper limit is not particularly limited, but can be, for example, 90% by mass or less, or 85% by mass or less. The range of the amount of water in the oil-in-water emulsion of the present invention can be expressed using two numerical values selected from the lower and upper numerical values, respectively, and for example, the oil-in-water emulsion of the present invention can contain water in an amount appropriately selected from the range of 15% by mass to 90% by mass, 45% by mass to 90% by mass, or 70% by mass to 85% by mass. The amount of water contained in the oil-in-water emulsion of the present invention is preferably greater than the amount of the hydrophobic substance in terms of volume ratio, and for example, the content of the hydrophobic substance and water can be greater than 1:1 in terms of volume ratio (hydrophobic substance:water), for example, 1:2 or more, 1:3 or more, 1:4 or more, 1:5 or more, 1:6 or more, 1:10 or more, 1:15 or more, or 1:20 or more, and the upper limit of the amount of water is not particularly limited, but can be 1:90 or less, 1:80 or less, 1:70 or less, 1:60 or less, or 1:50 or less. By adjusting the amounts of water and hydrophobic substance contained in the oil-in-water emulsion of the present invention to the above ranges, stickiness, sliminess, etc. can be suppressed.
「サイクロデキストリン」は、ブドウ糖を構成単位とする環状無還元マルトオリゴ糖を意味し、ブドウ糖の数が6つのα-サイクロデキストリン、7つのβ-サイクロデキストリン、8つのγ-サイクロデキストリンが挙げられる。本発明においては、α-、β-、γ-サイクロデキストリン、及びそれらの誘導体、ならびにそれらの任意の組み合わせを用いることができる。サイクロデキストリンの誘導体としては、例えば、エチルサイクイロデキストリン、メチルサイクロデキストリン、ヒドロキシエチルサイクロデキストリン、ヒドロキシプロピルサイクロデキストリン、メチルアミノサイクロデキストリン、アミノサイクロデキストリン、カルボキシエチルサイクロデキストリン、カルボキシメチルサイクロデキストリン、スルフォキシエチルサイクロデキストリン、スルフォキシルサイクロデキストリン、アセチルサイクロデキストリン、分岐サイクロデキストリン、サイクロデキストリン脂肪酸エステル、グルコシルサイクロデキストリン、マルトシルサイクロデキストリン等が挙げられるが、これらに限定はされない。好ましくはα-サイクロデキストリンを使用する。α-サイクロデキストリンは水への溶解性が高く、ざらつきの少ない水中油型エマルジョンを得ることができる。 "Cyclodextrin" refers to a cyclic non-reducing maltooligosaccharide whose constituent unit is glucose, and examples of this include α-cyclodextrin, which has six glucose units, β-cyclodextrin, which has seven glucose units, and γ-cyclodextrin, which has eight glucose units. In the present invention, α-, β-, and γ-cyclodextrins, as well as derivatives thereof, and any combination thereof can be used. Examples of cyclodextrin derivatives include, but are not limited to, ethyl cyclodextrin, methyl cyclodextrin, hydroxyethyl cyclodextrin, hydroxypropyl cyclodextrin, methylamino cyclodextrin, amino cyclodextrin, carboxyethyl cyclodextrin, carboxymethyl cyclodextrin, sulfoxyethyl cyclodextrin, sulfoxyl cyclodextrin, acetyl cyclodextrin, branched cyclodextrin, cyclodextrin fatty acid ester, glucosyl cyclodextrin, and maltosyl cyclodextrin. α-cyclodextrin is preferably used. α-cyclodextrin is highly soluble in water, and can be used to obtain an oil-in-water emulsion with little roughness.
本発明の水中油型エマルジョンにおいてサイクロデキストリンは、増粘多糖類と共に水中油型エマルジョンの乳化や安定性に寄与し、かつ目的の用途における利用形態において所望の使用感を得ることが可能な量で含めることができる。例えば、本発明の水中油型エマルジョンにはサイクロデキストリンを、0.5質量%以上、1質量%以上、2.5質量%以上、3質量%以上、4質量%以上、4.5質量%以上、又は5質量%以上の量で含み、その上限は特に限定されるものではないが、例えば、15質量%以下、10質量%以下、9質量%以下、8質量%以下、7質量%以下、もしくは6質量%以下とすることができる。本発明の水中油型エマルジョンにおけるサイクロデキストリンの量の範囲は前記下限及び上限の数値よりそれぞれ選択される2つの数値を用いて表すことができ、例えば、本発明の水中油型エマルジョンにはサイクロデキストリンを、0.5質量%~15質量%、例えば1質量%~15質量%、2.5質量%~10質量%、2.5質量%~9質量%、3質量%~9質量%、4質量%~8質量%、4.5質量%~9質量%又は5質量%~7質量%、好ましくは2.5質量%~9質量%、又は4.5質量%~9質量%の範囲より適宜選択される量で含めることができる。サイクロデキストリンの量が0.5質量%よりも少ないと当該水中油型エマルジョンの乳化や安定性が不十分となる場合があり、一方、15質量%よりも多い場合には当該水中油型エマルジョンの粘性が高くなりすぎる場合や、きしみ感が強くなる場合があり、いずれにおいても目的の用途における利用形態において、有効成分を滞留させることができない場合や、所望の使用感を得ることができない場合がある。 In the oil-in-water emulsion of the present invention, cyclodextrin can be included in an amount that contributes to the emulsification and stability of the oil-in-water emulsion together with the thickening polysaccharide, and that allows the desired feeling of use to be obtained in the form of use in the intended application. For example, the oil-in-water emulsion of the present invention contains cyclodextrin in an amount of 0.5% by mass or more, 1% by mass or more, 2.5% by mass or more, 3% by mass or more, 4% by mass or more, 4.5% by mass or more, or 5% by mass or more, and the upper limit is not particularly limited, but can be, for example, 15% by mass or less, 10% by mass or less, 9% by mass or less, 8% by mass or less, 7% by mass or less, or 6% by mass or less. The range of the amount of cyclodextrin in the oil-in-water emulsion of the present invention can be expressed using two numerical values selected from the above-mentioned lower and upper numerical values, respectively. For example, the oil-in-water emulsion of the present invention can contain cyclodextrin in an amount appropriately selected from the range of 0.5% by mass to 15% by mass, for example, 1% by mass to 15% by mass, 2.5% by mass to 10% by mass, 2.5% by mass to 9% by mass, 3% by mass to 9% by mass, 4% by mass to 8% by mass, 4.5% by mass to 9% by mass, or 5% by mass to 7% by mass, preferably 2.5% by mass to 9% by mass, or 4.5% by mass to 9% by mass. If the amount of cyclodextrin is less than 0.5% by mass, the emulsification and stability of the oil-in-water emulsion may be insufficient, while if it is more than 15% by mass, the viscosity of the oil-in-water emulsion may become too high or it may have a strong squeaky feeling. In either case, it may not be possible to retain the active ingredient in the intended application or to obtain the desired feel when used.
本発明において「増粘多糖類」とは、一般的に、水に溶解し、粘性を付与する(増粘安定剤、水溶性糊料等とも呼ばれる場合がある)多糖類を意味する。本発明において利用可能な増粘多糖類としては、飲食品や医薬品(医薬部外品を含む)、化粧品等の製造において通常用いられている成分を利用することが可能であり、特に限定はされない。増粘多糖類はいずれか単独で用いてもよいし、異なる増粘多糖類を組み合わせて用いてもよく、本発明の滞留剤の利用態様に応じて、適当なものを選択して用いることができる。本発明において「増粘多糖類」とは、好ましくは、カルボキシメチルセルロース(CMC)、キサンタンガム、ローカストビーンガム、グアーガム、グルコマンナン、κ-カラギーナン、ι-カラギーナン、λ-カラギーナン、タマリンドガム、ジェランガム、アラビアガム、ペクチン、リン酸架橋でんぷん、ヒドロキシプロピルでんぷん、ヒドロキシプロピル化リン酸架橋でんぷん、トラガントガム、ヒドロキシプロピルセルロース、メチルセロース、ヒドロキシプロピルメチルセルロース、ヒドロキシエチルセルロース等を挙げることができ、これらのいずれかを単独で用いてもよいし、異なる種類のものを二種以上組み合わせて用いてもよい。 In the present invention, "thickening polysaccharides" generally means polysaccharides that dissolve in water and impart viscosity (sometimes also called thickening stabilizers, water-soluble thickeners, etc.). Thickening polysaccharides that can be used in the present invention include ingredients that are commonly used in the manufacture of foods and beverages, medicines (including quasi-drugs), cosmetics, etc., and are not particularly limited. Any thickening polysaccharide may be used alone, or different thickening polysaccharides may be used in combination, and an appropriate one may be selected and used depending on the usage mode of the retention agent of the present invention. In the present invention, the "thickening polysaccharide" preferably includes carboxymethylcellulose (CMC), xanthan gum, locust bean gum, guar gum, glucomannan, κ-carrageenan, ι-carrageenan, λ-carrageenan, tamarind gum, gellan gum, gum arabic, pectin, phosphate cross-linked starch, hydroxypropyl starch, hydroxypropylated phosphate cross-linked starch, tragacanth gum, hydroxypropyl cellulose, methyl cellulose, hydroxypropyl methyl cellulose, hydroxyethyl cellulose, etc. Any of these may be used alone, or two or more different types may be used in combination.
本発明において「増粘多糖類」は、より好ましくは、カルボキシメチルセルロース(CMC)、キサンタンガム、ローカストビーンガム、グアーガム、グルコマンナン、κ-カラギーナン、ι-カラギーナン、λ-カラギーナン、タマリンドガム、及び、ジェランガムであり、さらに好ましくは、カルボキシメチルセルロース(CMC)、グルコマンナン、タマリンドガム、及びキサンタンガムである。これらの増粘多糖類は特に、本発明の水中油型エマルジョンにとりわけ高い乳化安定性を付与することができる。 In the present invention, the "thickening polysaccharide" is more preferably carboxymethylcellulose (CMC), xanthan gum, locust bean gum, guar gum, glucomannan, κ-carrageenan, ι-carrageenan, λ-carrageenan, tamarind gum, and gellan gum, and even more preferably carboxymethylcellulose (CMC), glucomannan, tamarind gum, and xanthan gum. These thickening polysaccharides can particularly impart high emulsion stability to the oil-in-water emulsion of the present invention.
本発明の水中油型エマルジョンにおいて増粘多糖類は、サイクロデキストリンと共に水中油型エマルジョンの乳化や安定性に寄与し、かつ目的の用途における利用形態において所望の使用感を得ることが可能な量で含めることができる。例えば、本発明の水中油型エマルジョンには増粘多糖類を、0.05質量%以上、0.1質量%以上、0.2質量%以上、又は0.3質量%以上の量で含み、その上限は特に限定されるものではないが、例えば、1質量%以下、0.8質量%以下、0.7質量%以下、0.6質量%以下、又は0.5質量%以下とすることができる。本発明の水中油型エマルジョンにおける増粘多糖類の量の範囲は前記下限及び上限の数値よりそれぞれ選択される2つの数値を用いて表すことができ、例えば、本発明の水中油型エマルジョンには、増粘多糖類を、0.05質量%~1質量%、0.1質量%~1質量%、0.2質量%~0.8質量%、又は0.2質量%~0.5質量%の範囲より適宜選択される量で含めることができる。増粘多糖類の量が0.05質量%よりも少ないと当該水中油型エマルジョンの乳化や安定性が不十分となる場合があり、一方、1質量%よりも多い場合には当該水中油型エマルジョンの粘性が高くなりすぎる場合があり、いずれにおいても目的の用途における利用形態において、有効成分を滞留させることができない場合や、所望の使用感を得ることができない場合がある。 In the oil-in-water emulsion of the present invention, the thickening polysaccharide can be contained in an amount that contributes to the emulsification and stability of the oil-in-water emulsion together with cyclodextrin and that allows the desired feeling of use to be obtained in the form of use for the intended application. For example, the oil-in-water emulsion of the present invention contains the thickening polysaccharide in an amount of 0.05% by mass or more, 0.1% by mass or more, 0.2% by mass or more, or 0.3% by mass or more, and the upper limit is not particularly limited, but can be, for example, 1% by mass or less, 0.8% by mass or less, 0.7% by mass or less, 0.6% by mass or less, or 0.5% by mass or less. The range of the amount of thickening polysaccharide in the oil-in-water emulsion of the present invention can be expressed by using two numerical values selected from the above lower and upper numerical values, respectively. For example, the oil-in-water emulsion of the present invention can contain the thickening polysaccharide in an amount appropriately selected from the range of 0.05% by mass to 1% by mass, 0.1% by mass to 1% by mass, 0.2% by mass to 0.8% by mass, or 0.2% by mass to 0.5% by mass. If the amount of thickening polysaccharide is less than 0.05% by mass, the emulsification and stability of the oil-in-water emulsion may be insufficient, while if it is more than 1% by mass, the viscosity of the oil-in-water emulsion may be too high. In either case, the active ingredient may not be retained or the desired feeling of use may not be obtained in the form of use for the intended purpose.
本発明の水中油型エマルジョンにおいては、上記サイクロデキストリンと上記増粘多糖類の併用により水中油型エマルジョンの乳化や安定性を付与する。上記サイクロデキストリンと上記増粘多糖類の併用によりもたらされる水中油型エマルジョンの乳化や安定性は、一般的なゲル化剤が水に溶解され冷却することにより形成される3次元マトリックスゲルに依拠するものではなく(好ましくは、3次元マトリックスゲルを含むものではなく)、下記実施例により詳述するように、上記サイクロデキストリンと上記増粘多糖類との間で生じる水素結合による相互作用の存在によるものであると考えられる。また、本発明の水中油型エマルジョンは、上記サイクロデキストリンと上記増粘多糖類の併用により、乳化や安定性を有するものであることから、従来乳化組成物の製造において一般的に利用されている乳化剤を実質的に含まないものとしてもよく、好ましくは当該乳化剤を実質的に含まない。本発明において「乳化剤を実質的に含まない」とは、本発明の水中油型エマルジョンにおいて、乳化剤が乳化作用を発揮する態様で含まれないことを意味し、乳化剤が一切含まれないことを意図するものではない。本発明は、乳化剤を実質的に含まないことにより、例えば、本発明の水中油型エマルジョンを適用する場合に、刺激が少ない、アレルゲン性が低い等の安全性の高い有利な水中油型エマルジョンを得ることができる。「従来乳化組成物の製造において一般的に利用されている乳化剤」としては、例えば、タンパク質、ペプチドもしくはそれらの加水分解物、グリセリン脂肪酸エステル、有機酸モノグリセリド、ポリグリセリン脂肪酸エステル、ポリオキシエチレングリセリン脂肪酸エステル、ソルビタン脂肪酸エステル、プロピレングリコール脂肪酸エステル、ポリオキシエチレン脂肪酸エステル、ポリグリセリン縮合リシノレイン酸エステル、ソルビタン脂肪酸エステル、ポリオキシエチレンソルビット脂肪酸エステル、ショ糖脂肪酸エステル、レシチン、酵素分解レシチン、ポリエチレングリコール、ポリプロピレングリコール等が挙げられるが、これらに限定はされない。 In the oil-in-water emulsion of the present invention, the emulsification and stability of the oil-in-water emulsion are imparted by the combined use of the cyclodextrin and the thickening polysaccharide. The emulsification and stability of the oil-in-water emulsion brought about by the combined use of the cyclodextrin and the thickening polysaccharide do not depend on a three-dimensional matrix gel formed by dissolving a general gelling agent in water and cooling (preferably does not include a three-dimensional matrix gel), but is considered to be due to the presence of an interaction caused by hydrogen bonds generated between the cyclodextrin and the thickening polysaccharide, as described in detail in the following examples. In addition, since the oil-in-water emulsion of the present invention has emulsification and stability due to the combined use of the cyclodextrin and the thickening polysaccharide, it may be substantially free of emulsifiers commonly used in the production of conventional emulsion compositions, and preferably does not substantially contain the emulsifier. In the present invention, "substantially free of emulsifiers" means that the emulsifier is not included in the oil-in-water emulsion of the present invention in a form that exerts an emulsifying effect, and does not mean that no emulsifier is included at all. By being substantially free of emulsifiers, the present invention can obtain an advantageous oil-in-water emulsion that is highly safe, for example, less irritating and less allergenic, when the oil-in-water emulsion of the present invention is applied. Examples of "emulsifiers commonly used in the production of conventional emulsion compositions" include, but are not limited to, proteins, peptides or hydrolysates thereof, glycerin fatty acid esters, organic acid monoglycerides, polyglycerin fatty acid esters, polyoxyethylene glycerin fatty acid esters, sorbitan fatty acid esters, propylene glycol fatty acid esters, polyoxyethylene fatty acid esters, polyglycerin condensed ricinoleic acid esters, sorbitan fatty acid esters, polyoxyethylene sorbit fatty acid esters, sucrose fatty acid esters, lecithin, enzymatically decomposed lecithin, polyethylene glycol, polypropylene glycol, etc.
本発明の水中油型エマルジョンの形態は特に限定されず、上記水分含量を有する形態の他、水分含量を減少させて調製された、半固体/半液体(ゲル、ゾル等)や乾燥体(例えば、粉体、フレーク等)の形態で提供とすることができる。このような半固体/半液体(ゲル、ゾル等)や乾燥体(例えば、粉体、フレーク等)の形態は、上記水分含量を有する形態の水中油型エマルジョンを得たのち、それを従来公知の乾燥手段に付して、当該水中油型エマルジョンの水分含量を減少させることにより得ることができる。このような乾燥手段としては、例えば、凍結乾燥、加熱乾燥、風乾、噴霧乾燥、ドラム乾燥、熱風乾燥、真空乾燥等が挙げられるが、これらに限定はされない。乾燥手段に付された後の当該水中油型エマルジョンの水分含量は、目的とする形態に応じて適宜選択することが可能である。乾燥体の形態であれば例えば、15質量%未満、10質量%以下、5質量%以下、又は1質量%以下とすることができる。乾燥手段に付された後の当該水中油型エマルジョンの水分含量の下限は特に限定されないが、0質量%以上、0質量%超、0.1質量%以上、0.5質量%以上、0.6質量%以上、0.7質量%以上、又は0.8質量%以上とすることができる。当該乾燥体の形態の水分含量の範囲は前記上限及び下限の数値よりそれぞれ選択される2つの数値を用いて表すことができ、例えば、当該水中油型エマルジョンの水分含量は、0質量%~15質量%未満、0質量%超15質量%未満、0.1質量%~15質量%未満、0.1質量%~10質量%、0.5質量%~5質量%、0.5質量%~1質量%、0.6質量%~1質量%、0.7質量%~1質量%、又は0.8質量%~1質量%とすることができる。乾燥手段に付された後の本発明の水中油型エマルジョンは相転移を生じて油中水型エマルジョンを生じるものではなく、そして、とりわけ、乾燥体の形態は、高温(例えば、100℃~200℃程度)条件、及び/又は多湿(例えば、~95%湿度程度)条件に付された後においても、変色や溶解を生じることのない、高い耐熱性及び耐湿性を有するものである。 The form of the oil-in-water emulsion of the present invention is not particularly limited, and in addition to the form having the above water content, it can be provided in the form of a semi-solid/semi-liquid (gel, sol, etc.) or a dried body (e.g., powder, flakes, etc.) prepared by reducing the water content. Such a semi-solid/semi-liquid (gel, sol, etc.) or dried body (e.g., powder, flakes, etc.) form can be obtained by obtaining an oil-in-water emulsion having the above water content, and then subjecting it to a conventionally known drying means to reduce the water content of the oil-in-water emulsion. Examples of such drying means include, but are not limited to, freeze drying, heat drying, air drying, spray drying, drum drying, hot air drying, vacuum drying, etc. The water content of the oil-in-water emulsion after being subjected to the drying means can be appropriately selected depending on the desired form. If it is in the form of a dried body, it can be, for example, less than 15% by mass, 10% by mass or less, 5% by mass or less, or 1% by mass or less. The lower limit of the water content of the oil-in-water emulsion after being subjected to the drying means is not particularly limited, but may be 0% by mass or more, more than 0% by mass, 0.1% by mass or more, 0.5% by mass or more, 0.6% by mass or more, 0.7% by mass or more, or 0.8% by mass or more. The range of the water content in the form of the dried product can be expressed using two numerical values selected from the upper and lower numerical values, respectively, and for example, the water content of the oil-in-water emulsion can be 0% by mass to less than 15% by mass, more than 0% by mass to less than 15% by mass, 0.1% by mass to less than 15% by mass, 0.1% by mass to 10% by mass, 0.5% by mass to 5% by mass, 0.5% by mass to 1% by mass, 0.6% by mass to 1% by mass, 0.7% by mass to 1% by mass, or 0.8% by mass to 1% by mass. The oil-in-water emulsion of the present invention after being subjected to the drying means does not undergo a phase transition to produce a water-in-oil emulsion, and in particular, the dried form has high heat resistance and moisture resistance, and does not discolor or dissolve even after being subjected to high temperature (e.g., about 100°C to 200°C) conditions and/or high humidity (e.g., about 95% humidity) conditions.
本発明の水中油型エマルジョンには、上記成分に加えて、必要に応じてさらに、飲食品や医薬品(医薬部外品を含む)、化粧品等の目的の用途における利用形態の製造において通常用いられている成分(以下、「その他の成分」と記載する)を、本発明の効果を損なわない範囲で、所望の利用形態に応じた量にて適宜配合することができる。このようなその他の成分としては、例えば、賦形剤、崩壊剤、滑沢剤、結合剤、希釈剤、緩衝剤、懸濁化剤、増粘剤、保存剤、抗菌剤、防腐剤、酸化防止剤、紫外線吸収剤、着色剤、顔料、染料、色素、潤滑剤、可塑剤、溶剤、溶解補助剤、等張化剤、矯味矯臭剤、ビタミン類、界面活性剤、pH調整剤、キレート剤等が挙げられるが、これらに限定はされない。 In addition to the above components, the oil-in-water emulsion of the present invention may further contain, as necessary, components (hereinafter referred to as "other components") that are normally used in the manufacture of intended uses such as food and beverages, medicines (including quasi-drugs), and cosmetics, in amounts appropriate to the desired use form, within a range that does not impair the effects of the present invention. Examples of such other components include, but are not limited to, excipients, disintegrants, lubricants, binders, diluents, buffers, suspending agents, thickeners, preservatives, antibacterial agents, preservatives, antioxidants, UV absorbers, colorants, pigments, dyes, pigments, lubricants, plasticizers, solvents, solubilizers, isotonicity agents, flavorings, vitamins, surfactants, pH adjusters, and chelating agents.
本発明の水中油型エマルジョンは、水、疎水性物質、サイクロデキストリン、及び、増粘多糖類、ならびに必要に応じてその他の成分を上記の量にて混合、攪拌することにより製造することができる。各成分は全て一緒に混合、攪拌してもよいし、各成分を別々にもしくは任意の組み合わせで順次添加して(順序は問わない)混合、攪拌してもよい。混合、攪拌して得られた水中油型エマルジョンは、加熱殺菌処理に付してもよい。 The oil-in-water emulsion of the present invention can be produced by mixing and stirring the water, hydrophobic substance, cyclodextrin, thickening polysaccharide, and other components as necessary in the amounts described above. All of the components may be mixed and stirred together, or the components may be added separately or in any combination in sequence (in any order) and mixed and stirred. The oil-in-water emulsion obtained by mixing and stirring may be subjected to heat sterilization.
また、混合、攪拌して得られた水中油型エマルジョンは、必要に応じてさらに乾燥手段に付してもよい。乾燥手段は、上記従来公知の乾燥手段により行うことができ、当該水中油型エマルジョンの水分含量を、半固体/半液体(ゲル、ゾル等)や乾燥体の目的とする形状に応じて適宜調整することができる。得られた乾燥体は、必要に応じてさらに破砕、粉砕、又は摩砕処理に付して粉体やフレーク等の形態とすることができる。乾燥手段に付されて得られた水中油型エマルジョンには、必要に応じてその他の成分を上記の量にて混合、攪拌してもよく、ならびに/あるいは、加熱殺菌処理に付してもよい。 The oil-in-water emulsion obtained by mixing and stirring may be subjected to drying means as required. The drying means may be any of the conventionally known drying means described above, and the water content of the oil-in-water emulsion may be appropriately adjusted depending on the desired shape of the semi-solid/semi-liquid (gel, sol, etc.) or dried body. The resulting dried body may be subjected to further crushing, pulverization, or grinding treatment as required to obtain a powder, flakes, or the like. The oil-in-water emulsion obtained by drying may be mixed and stirred with other components in the amounts described above as required, and/or may be subjected to heat sterilization treatment.
2.用途
本発明の水中油型エマルジョンは、有効成分を滞留させるための滞留剤として用いることができる。
2. Uses The oil-in-water emulsion of the present invention can be used as a retention agent for retaining an active ingredient.
本発明において「滞留剤」とは、有効成分を所定の部位に保持又は維持することにより長く留めることができ、それによって当該滞留剤を使用しない場合と比べて、当該有効成分の効果を増強、及び/又は長く維持することを可能とするものである。本発明の滞留剤は、動物に有効成分と共に投与又は摂取されると、水中油型エマルジョンが適用部位の組織に付着し、そこで、有効成分を保持し、及び/又は有効成分を吸収・吸着して保持することによって、留めることができ、当該滞留剤を使用しない場合と比べて、有効成分による効果を増強、及び/又は長く維持することができる。 In the present invention, a "retention agent" is an agent that can retain or maintain an active ingredient at a specific site for a longer period of time, thereby enabling the effect of the active ingredient to be enhanced and/or maintained for a longer period of time compared to when the retention agent is not used. When the retention agent of the present invention is administered or ingested by an animal together with an active ingredient, the oil-in-water emulsion adheres to the tissue at the application site, where it can retain the active ingredient and/or absorb, adsorb and retain the active ingredient, thereby enabling the effect of the active ingredient to be enhanced and/or maintained for a longer period of time compared to when the retention agent is not used.
本発明において「動物」とは、特に限定されるものではなく任意の動物であってよいが、好ましくは哺乳動物であり、例えば、ヒト、家畜動物(ウシ、ウマ、ヒツジ、ブタ、ヤギ等)、愛玩動物(イヌ、ネコ、ウサギ、ウサギ、ハムスター、モルモット等)が挙げられるが(これらに限定はされない)、より好ましくはヒトである。 In the present invention, "animal" is not particularly limited and may be any animal, but is preferably a mammal, and examples thereof include (but are not limited to) humans, livestock animals (cattle, horses, sheep, pigs, goats, etc.), and pet animals (dogs, cats, rabbits, hamsters, guinea pigs, etc.), and more preferably humans.
本発明において「組織」とは、皮膚、口腔、食道、肛門、膣、鼻腔、気管、気管支、胃、小腸、大腸、卵管、子宮、胸膜、腹膜、血管内皮、肺胞、甲状腺(濾胞)、尿細管、尿管、膀胱等でみられる各種上皮組織や毛髪、爪、歯等が挙げられ、目的とする適用部位に応じて適宜選択することができる。本発明において「上皮組織」とは、好ましくは皮膚、口腔、食道、鼻腔、気管、気管支等でみられる各種上皮組織であり、より好ましくは口腔内の上皮組織である。 In the present invention, "tissue" refers to various epithelial tissues found in the skin, oral cavity, esophagus, anus, vagina, nasal cavity, trachea, bronchi, stomach, small intestine, large intestine, fallopian tube, uterus, pleura, peritoneum, vascular endothelium, alveoli, thyroid gland (follicles), renal tubules, ureters, bladder, etc., as well as hair, nails, teeth, etc., and can be appropriately selected depending on the intended application site. In the present invention, "epithelial tissue" refers preferably to various epithelial tissues found in the skin, oral cavity, esophagus, nasal cavity, trachea, bronchi, etc., and more preferably to epithelial tissue in the oral cavity.
本発明において「有効成分と共に投与又は摂取される」とは、本発明の水中油型エマルジョンと有効成分とが、適用部位の組織にて併存できる時間内に両者が投与又は摂取されればよく、例えば、本発明の水中油型エマルジョンと有効成分とを一つの組成物中に含めて同時に投与又は摂取してもよいし、あるいは両者を別々の形態及び/又は別々の投与経路で、同時に又は前後して(好ましくは、本発明の水中油型エマルジョン、次いで有効成分の順序で)投与又は摂取してもよい。「投与」は、適用部位である組織に本発明の水中油型エマルジョンと有効成分とを送達できればよく、本発明の水中油型エマルジョンと有効成分の形態や量等に応じて適宜選択することができる。例えば、「投与」には、経口投与、噴霧投与、吸引、経鼻投与、口腔内投与、直腸内投与、経皮投与、塗布等が挙げられるが、これらに限定はされない。好ましくは「投与」とは、経口投与、噴霧投与、吸引、口腔内投与、又は塗布である。 In the present invention, "administered or ingested together with an active ingredient" means that the oil-in-water emulsion of the present invention and the active ingredient are both administered or ingested within a time period during which they can coexist in the tissue at the application site. For example, the oil-in-water emulsion of the present invention and the active ingredient may be administered or ingested simultaneously in one composition, or they may be administered or ingested in separate forms and/or separate administration routes, either simultaneously or one after the other (preferably, the oil-in-water emulsion of the present invention, followed by the active ingredient). "Administration" is sufficient as long as the oil-in-water emulsion of the present invention and the active ingredient can be delivered to the tissue at the application site, and can be appropriately selected depending on the form and amount of the oil-in-water emulsion of the present invention and the active ingredient. For example, "administration" includes, but is not limited to, oral administration, spray administration, inhalation, nasal administration, oral administration, rectal administration, transdermal administration, and application. Preferably, "administration" is oral administration, spray administration, inhalation, oral administration, or application.
本発明において「有効成分」としては、水溶性成分であるか、あるいは上記疎水性物質に親和性を有する成分(例えば、親油性成分等)が挙げられる。水溶性成分は、本発明の水中油型エマルジョンにおける水分中に、好ましくは、増粘多糖類及び/又はサイクロデキストリンと結合(例えば、水素結合)して、保持されると考えられる。一方、上記疎水性物質に親和性を有する成分は、本発明の水中油型エマルジョンにおける疎水性物質中に保持されると考えられる。本発明における「有効成分」としては、飲食品における味質の成分(塩化ナトリウム、塩化カリウム等の塩味成分;糖類(ブドウ糖、果糖、ショ糖、麦芽糖、オリゴ糖、異性化糖等)、糖アルコール類(キシリトール、ソルビトール、グリセリン、エリトリトール等)、天然甘味料(ステビア、グリチルリチン、ソーマチン等)、人工甘味料(アスパルテーム、アセスルファムカリウム、スクラロース等)等の甘味成分;クエン酸、コハク酸、乳酸、酒石酸、酢酸、フマル酸、リンゴ酸、グルコン酸、アスコルビン酸等の酸味成分;グルタミン酸、イノシン酸、グアニル酸等の旨味成分;アルカロイド類(カフェイン、キニン、ストリキニン、テオブロミン等)、テルペン類(リモノイド、リモニン、オバクノン、ノミリン、ククルビタシン、フムロン、ルプロン等)、配糖体類(テルペン配糖体、フラバノン配糖体、ナリジン、ネオヘスペリジン等)、アミノ酸類(トリプトファン、フェニルアラニン、トリプシン、アルギニン、バリン、ロイシン、イソロイシン、プロリン等)、カゼインや大豆タンパク質等の苦味成分;カプサイシン、ピペリン、サンショオール、ショウガオール、ジンゲロール、ジアリルジスルフィド、p-ヒドロキシベンジル、イソチオシアネート等の辛味成分;タンニン、カテキン、テアフラビン、テアルビジン等の渋味成分等(これらに限定はされない))ならびにそれらを含む食材、調味料、スパイス等や、医薬品(医薬部外品を含む)及び化粧品(以下、「医薬品等」と記載する)における所定の処置・目的のために用いられる成分(例えば、薬剤、殺菌剤、抗菌剤、抗生物質、酵素、抗体、ビタミン類、ミネラル類、アミノ酸類、清涼剤、防臭剤、保湿剤、香料等(これらに限定はされない))が挙げられる。 In the present invention, the "active ingredient" may be a water-soluble ingredient or an ingredient having affinity for the above-mentioned hydrophobic substance (e.g., lipophilic ingredient, etc.). The water-soluble ingredient is considered to be retained in the water in the oil-in-water emulsion of the present invention, preferably by bonding (e.g., hydrogen bonding) with the thickening polysaccharide and/or cyclodextrin. On the other hand, the ingredient having affinity for the above-mentioned hydrophobic substance is considered to be retained in the hydrophobic substance in the oil-in-water emulsion of the present invention. In the present invention, the "active ingredient" may be a component of taste in food and drink (salty ingredients such as sodium chloride and potassium chloride; sweet ingredients such as sugars (glucose, fructose, sucrose, maltose, oligosaccharides, isomerized sugar, etc.), sugar alcohols (xylitol, sorbitol, glycerin, erythritol, etc.), natural sweeteners (stevia, glycyrrhizin, thaumatin, etc.), and artificial sweeteners (aspartame, acesulfame potassium, sucralose, etc.). Flavor components: Sour components such as citric acid, succinic acid, lactic acid, tartaric acid, acetic acid, fumaric acid, malic acid, gluconic acid, and ascorbic acid; umami components such as glutamic acid, inosinic acid, and guanylic acid; alkaloids (caffeine, quinine, strychnine, theobromine, etc.), terpenes (limonoids, limonin, obacunone, nomilin, cucurbitacin, humulone, lupulone, etc.), glycosides (terpene glycosides, flavanone glycosides, nalidinone, naphthalene ... , neohesperidin, etc.), amino acids (tryptophan, phenylalanine, trypsin, arginine, valine, leucine, isoleucine, proline, etc.), bitter components such as casein and soy protein; pungent components such as capsaicin, piperine, sanshool, shogaol, gingerol, diallyl disulfide, p-hydroxybenzyl, isothiocyanate, etc.; astringent components such as tannin, catechin, theaflavin, thearubigin, etc. (not limited to these)) as well as food ingredients, seasonings, spices, etc. that contain them, and ingredients used for specific treatments and purposes in medicines (including quasi-drugs) and cosmetics (hereinafter referred to as "medicines, etc.") (for example, drugs, disinfectants, antibacterial agents, antibiotics, enzymes, antibodies, vitamins, minerals, amino acids, cooling agents, deodorants, moisturizers, fragrances, etc. (not limited to these)).
本発明の滞留剤は、飲食品や医薬品等の有効成分を滞留させるために、飲食品や医薬品等に添加して用いることができる。その添加量は、飲食品や医薬品等の有効成分を、所定の部位に保持又は維持することにより、当該滞留剤を使用しない場合と比べて、長く留めることができ、当該有効成分の効果を、増強、及び/又は長く維持することを可能とすることが可能な量であればよく、有効成分の種類や量、飲食品や医薬品等の種類や形態に応じて、適宜決定することが可能である。例えば、飲食品や医薬品等には、本発明の滞留剤をその疎水性物質の量にして0.1質量%以上、0.5質量%以上、1質量%以上、2.5質量%以上、5質量%以上、又は7質量%以上の量で含めることができ、その上限は特に限定されるものではないが、例えば、55質量%以下、50質量%以下、40質量%以下、30質量%以下、20質量%以下、又は10質量%以下とすることができる。飲食品や医薬品等における本発明の滞留剤の量の範囲は前記下限及び上限の数値よりそれぞれ選択される2つの数値を用いて表すことができ、例えば、飲食品や医薬品等には本発明の滞留剤をその疎水性物質の量にして、0.5質量%~55質量%、0.5質量%~50質量%、0.5質量%~40質量%、0.5質量%~20質量%、又は0.5質量%~10質量%の範囲より適宜選択される量にて含めることができる。飲食品や医薬品等に含まれる本発明の滞留剤の量が上記範囲よりも少ないもしくは多い場合には、いずれにおいても目的の用途における利用形態において、有効成分を滞留させることができない場合がある。 The retention agent of the present invention can be added to food, beverages, medicines, etc. to retain the active ingredients of the food, beverages, medicines, etc. The amount of the retention agent added may be any amount that can retain or maintain the active ingredients of the food, beverages, medicines, etc. in a predetermined location for a longer period than when the retention agent is not used, and can enhance and/or maintain the effect of the active ingredients for a longer period, and can be appropriately determined depending on the type and amount of the active ingredients, the type and form of the food, beverages, medicines, etc. For example, the retention agent of the present invention can be contained in the food, beverages, medicines, etc. in an amount of 0.1% by mass or more, 0.5% by mass or more, 1% by mass or more, 2.5% by mass or more, 5% by mass or more, or 7% by mass or more in terms of the amount of the hydrophobic substance, and the upper limit is not particularly limited, but can be, for example, 55% by mass or less, 50% by mass or less, 40% by mass or less, 30% by mass or less, 20% by mass or less, or 10% by mass or less. The range of the amount of the retention agent of the present invention in foods, beverages, medicines, etc. can be expressed using two numerical values selected from the above lower and upper numerical values, respectively. For example, the retention agent of the present invention can be contained in foods, beverages, medicines, etc. in an amount appropriately selected from the ranges of 0.5% to 55% by mass, 0.5% to 50% by mass, 0.5% to 40% by mass, 0.5% to 20% by mass, or 0.5% to 10% by mass, in terms of the amount of hydrophobic substance. If the amount of the retention agent of the present invention contained in foods, beverages, medicines, etc. is less or more than the above range, in either case, it may not be possible to retain the active ingredient in the form of use for the intended application.
なお、本明細書中、飲食品や医薬品等に含まれる各成分の量の記載は、当該飲食品や医薬品等の溶液や固形部分を除いた液状部分の(例えば、飲食品であれば、具材が除かれたソースやスープ等の液状部分の量)全質量を100質量%とする、質量%の量にて示される。当該量は、飲食品や医薬品等が液体の形態や液状部分を有さない形態である場合には、投与又は摂食時に適当な溶媒(例えば、水、湯、生理食塩水、緩衝液等)を加えて/適当な溶媒に加えて調製された溶液、あるいは、当該飲食品や医薬品等が適用部位の組織における水分(例えば、唾液等の体液)で溶解された溶液における量とすることができる。 In this specification, the amount of each component contained in a food, drink, medicine, etc. is indicated in mass %, with the total mass of the liquid portion of the food, drink, medicine, etc. excluding the solution or solid portion (for example, in the case of a food, drink, the amount of the liquid portion such as sauce or soup excluding ingredients) being 100 mass %. When the food, drink, medicine, etc. is in a liquid form or in a form that does not have a liquid portion, the amount can be the amount in a solution prepared by adding/adding to an appropriate solvent (for example, water, hot water, saline, buffer solution, etc.) at the time of administration or ingestion, or the amount in a solution in which the food, drink, medicine, etc. is dissolved in water (for example, body fluids such as saliva) in the tissue at the application site.
飲食品や医薬品等には、本発明の滞留剤と有効成分を一緒に含めてもよいし(例えば、一つの組成物中に含めてもよく)、あるいは、本発明の滞留剤と有効成分とは別々の形態としてもよい(例えば、共に投与又は摂取される二つ以上の組成物中にそれぞれ含めてもよい)。 Foods, beverages, medicines, etc. may contain the retention agent of the present invention together with the active ingredient (e.g., in one composition), or the retention agent of the present invention and the active ingredient may be in separate forms (e.g., in two or more compositions that are administered or ingested together).
飲食品や医薬品等の形態は、目的の用途における利用形態(例えば、所定の製品等の形態)に応じて適宜選択することができ、固体、粉体、顆粒、フレーク、チュアブル錠、シート、フィルム、チューイングガム、液体、乳液、半固体/半液体(ゲル、ゾル、クリーム、ペースト、ムース等)、軟カプセル等(これらに限定はされない)、任意の形態をとることができる。ただし、適用部位の組織にて、本発明の滞留剤が、上記範囲となる量で、有効成分と共存することが好ましい。飲食品や医薬品等はその形態に応じて、必要に応じて、投与又は摂食時に、適当な溶媒(例えば、水、湯、生理食塩水、緩衝液等)を加えて/適当な溶媒に加えて、飲食品や医薬品等における本発明の滞留剤の含有量を上記範囲に調製した後に投与又は摂食することができる(このような形態の飲食品や医薬品等には、固体、粉体、顆粒、フレーク、液体、乳液、半固体/半液体(ゲル、ゾル、クリーム、ペースト、ムース等)等の形態が挙げられるが、これらに限定はされない)。あるいは、飲食品や医薬品等は適用部位の組織における水分(例えば、唾液等の体液)中に、本発明の滞留剤と有効成分とが溶解され、本発明の滞留剤の含有量を上記範囲とし作用させてもよい(このような形態の飲食品や医薬品等には、粉体、顆粒、チュアブル錠、シート、フィルム、チューイングガム等の形態が挙げられるが、これらに限定はされない)。 The form of the food, beverage, medicine, etc. can be appropriately selected according to the form of use in the intended application (for example, the form of a specified product, etc.), and can take any form, such as solid, powder, granules, flakes, chewable tablets, sheets, films, chewing gums, liquids, emulsions, semi-solid/semi-liquid (gels, sols, creams, pastes, mousses, etc.), soft capsules, etc. (but not limited to these). However, it is preferable that the retention agent of the present invention coexists with the active ingredient in the tissue at the application site in an amount within the above range. Depending on the form of the food, beverage, medicine, etc., an appropriate solvent (for example, water, hot water, saline, buffer solution, etc.) can be added/added to an appropriate solvent at the time of administration or ingestion as necessary to adjust the content of the retention agent of the present invention in the food, beverage, medicine, etc. to the above range, and then administered or ingested (such forms of food, beverage, medicine, etc. include, but are not limited to, solid, powder, granules, flakes, liquids, emulsions, semi-solid/semi-liquid (gels, sols, creams, pastes, mousses, etc.)). Alternatively, the food, beverage, medicine, etc. may be allowed to act by dissolving the retention agent of the present invention and the active ingredient in the moisture (e.g., body fluids such as saliva) in the tissue at the application site, and setting the content of the retention agent of the present invention within the above range (such forms of food, beverage, medicine, etc. include, but are not limited to, powder, granules, chewable tablets, sheets, films, chewing gum, etc.).
飲食品や医薬品等には、本発明の滞留剤や有効成分に加えて、必要に応じてさらに、目的の用途における利用形態(例えば、所定の製品等の形態)の製造において通常用いられている成分を、本発明の効果を損なわない範囲で、所望の利用形態に応じた量にて適宜配合することができる。このような成分としては、例えば、賦形剤、崩壊剤、滑沢剤、結合剤、希釈剤、緩衝剤、懸濁化剤、増粘剤、保存剤、抗菌剤、防腐剤、酸化防止剤、紫外線吸収剤、着色剤、顔料、染料、色素、潤滑剤、可塑剤、溶剤、溶解補助剤、等張化剤、矯味矯臭剤、香料、甘味料、呈味成分、酸味料、調味料、保湿剤、ビタミン類、界面活性剤、キレート剤、抗菌剤、乳化剤、水溶性有機溶媒、食材等が挙げられるが、これらに限定はされない。 In addition to the retention agent and active ingredient of the present invention, foods, beverages, medicines, etc. can further contain, as necessary, ingredients that are normally used in the manufacture of the intended form of use (e.g., the form of a specified product, etc.) in an amount appropriate to the desired form of use, within a range that does not impair the effects of the present invention. Examples of such ingredients include excipients, disintegrants, lubricants, binders, diluents, buffers, suspending agents, thickeners, preservatives, antibacterial agents, preservatives, antioxidants, UV absorbers, colorants, pigments, dyes, pigments, lubricants, plasticizers, solvents, solubilizers, isotonicity agents, flavorings, fragrances, sweeteners, taste components, acidulants, seasonings, moisturizers, vitamins, surfactants, chelating agents, antibacterial agents, emulsifiers, water-soluble organic solvents, food ingredients, etc., but are not limited to these.
一態様において、本発明の滞留剤は飲食品に含めて提供される。当該飲食品を喫食することにより、本発明の滞留剤における水中油型エマルジョンが口腔内の上皮組織に付着し、そこで共に摂取される有効成分、例えば、味質の成分を保持し、及び/又は味質の成分を吸収・吸着して保持することによって、滞留させ、有効成分がもたらす効果(例えば、味質の成分がもたらす風味や呈味)を、当該滞留剤を使用しない場合と比べて、増強、及び/又は長く維持することができる。このような利用態様における本発明の滞留剤は、風味増強剤や呈味増強剤等とも称される場合がある。 In one embodiment, the retention agent of the present invention is provided in a food or beverage. When the food or beverage is consumed, the oil-in-water emulsion in the retention agent of the present invention adheres to the epithelial tissue in the oral cavity, where it retains the active ingredients ingested therewith, such as taste ingredients, and/or absorbs, adsorbs and retains the taste ingredients, thereby retaining them, and the effect of the active ingredients (e.g., the flavor and taste brought about by the taste ingredients) can be enhanced and/or maintained for a longer period of time compared to when the retention agent is not used. The retention agent of the present invention in such a usage embodiment may also be referred to as a flavor enhancer or taste enhancer.
また、別の態様において、本発明の「滞留剤」は口腔内ケア製品に含めて提供される。当該製品を口に含むことにより、本発明の滞留剤における水中油型エマルジョンが口腔内の上皮組織に付着し、そこで共に投与される有効成分であるところの薬剤(例えば、虫歯予防・修復剤(塩化セチルピリジニウム(CPC)、塩化ベンザルコニウム、塩化ベンゼトニウム(BTC)、フッ化ナトリウム、モノフルオロリン酸ナトリウム等)、歯肉炎・歯周炎予防・改善剤(ε-アミノカプロン酸、イソプロピルメチルフェノール(シメン-5-オール)、アラントイン、グリチルリチン酸ジカリウム、β-グリチルレチン酸、塩化セチルピリジニウム(CPC)、ヒノキチオール、トリクロサン、トラネキサム酸、塩化ベンザルコニウム、塩化ベンゼトニウム(BTC)、トリクロサン、塩化ナトリウム、酢酸トコフェロール等)、口内炎予防・改善剤(アラントイン、グリチルリチン酸、トラネキサム酸等)、知覚過敏予防・抑制剤(乳酸アルミニウム、硝酸カリウム等)、プラーク予防・除去剤(デキストラナーゼ等)、歯石予防・除去剤(ポリリン酸ナトリウム、ピロリン酸ナトリウム等)、ステイン予防・除去剤(ポリリン酸ナトリウム、ポリエチレングリコール等)、口臭予防・除去剤(イソプロピルメチルフェノール(シメン-5-オール)、ラウロイルサルコシンナトリウム等)、口腔乾燥予防・抑制剤(ヒアルロン酸、乳タンパク質エキス、ラクトペルオキシダーゼ、グルコースオキシダーゼ、リゾチーム、ラクトフェリン、リン酸二カリウム、塩化カリウム、塩化カルシウム水和物、塩化ナトリウム、塩化マグネシウム、ピロカルピン塩酸塩、セビメリン塩酸塩水和物、アネトールトリチオン等)等が挙げられるが、これらに限定はされない)を保持し、及び/又は薬剤を吸収・吸着して保持することによって、滞留させ、薬剤がもたらす効果を、当該滞留剤を使用しない場合と比べて、増強、及び/又は長く維持することができる。このような口腔内ケア製品は従来公知の一般的な形態、例えば、洗口剤、洗口液、マウスウォッシュ、液状歯磨き剤、練り歯磨き剤、粉末状歯磨き剤、ジェル、フィルム、チューインガム、スプレー剤、液剤等とすることができる。 In another aspect, the "retention agent" of the present invention is provided in an oral care product. By holding the product in the mouth, the oil-in-water emulsion in the retention agent of the present invention adheres to the epithelial tissue in the oral cavity, where the active ingredient of the drug administered together (for example, caries prevention/repair agents (cetylpyridinium chloride (CPC), benzalkonium chloride, benzethonium chloride (BTC), sodium fluoride, sodium monofluorophosphate, etc.), gingivitis/periodontitis prevention/improvement agents (ε-aminocaproic acid, isopropylmethylphenol (cymen-5-ol), allantoin, dipotassium glycyrrhizinate, β-glycyrrhetinic acid, cetylpyridinium chloride (CPC), hinokitiol, triclosan, tranexamic acid, benzalkonium chloride, benzethonium chloride (BTC), triclosan, sodium chloride, tocopherol acetate, etc.), stomatitis prevention/improvement agents (allantoin, glycyrrhizic acid, tranexamic acid, etc.), and dentin hypersensitivity prevention/suppression agents (aluminum lactate, potassium nitrate, etc.)) , plaque prevention/removal agents (dextranase, etc.), tartar prevention/removal agents (sodium polyphosphate, sodium pyrophosphate, etc.), stain prevention/removal agents (sodium polyphosphate, polyethylene glycol, etc.), bad breath prevention/removal agents (isopropylmethylphenol (cymen-5-ol), sodium lauroyl sarcosine, etc.), dry mouth prevention/suppression agents (hyaluronic acid, milk protein extract, lactoperoxidase, glucose oxidase, lysozyme, lactoferrin, dipotassium phosphate, potassium chloride, calcium chloride hydrate, sodium chloride, magnesium chloride, pilocarpine hydrochloride, cevimeline hydrochloride hydrate, anethole trithione, etc.), but are not limited to these), and/or by absorbing/adsorbing and retaining the drug, the effect of the drug can be enhanced and/or maintained for a longer period of time compared to when the retention agent is not used. Such oral care products can be in the conventional forms known in the art, such as mouthwash, mouth rinse, mouthwash, liquid dentifrice, toothpaste, powdered dentifrice, gel, film, chewing gum, spray, liquid, etc.
また、別の態様において、本発明の「滞留剤」はヘアケア製品に含めて提供される。当該製品を髪に塗布することにより、本発明の滞留剤における水中油型エマルジョンが髪に付着し、そこで共に投与される有効成分、例えば、毛髪保護成分(加水分解卵殻膜、加水分解ケラチン、加水分解コラーゲン、加水分解シルク、加水分解コムギ、加水分解コムギタンパク、加水分解ダイズタンパク、グルタミン酸、アルギニン、ピロリドンカルボン酸、ジメチコン、アモジメチコン、ポリクオタニウム-10、キトサン等)、髪質改善成分(ステアリルトリモニウムブロミド、セトリモニウムブロミド、ステアリルトリモニウムクロリド等)、毛髪補修成分(オリーブ油、ホホバ油、アボカド油、スクアラン、ミリスチン酸イソプロピル、イソステアリルアルコール、オレイルアルコール、卵黄脂肪油、吸着精製ラノリン、ダイズステロール、コレステロール、セラミド等)、保湿成分(ヒアルロン酸、グリセリン、加水分解卵殻膜、加水分解ケラチン、加水分解コラーゲン、加水分解シルク、加水分解コムギ、加水分解コムギタンパク、加水分解ダイズタンパク、グルタミン酸、アルギニン、ピロリドンカルボン酸、卵黄脂肪油、吸着精製ラノリン、ダイズステロール、コレステロール、セラミド等(これらに限定はされない)を保持し、及び/又はこれらを吸収・吸着して保持することによって、滞留させ、有効成分がもたらす効果を、当該滞留剤を使用しない場合と比べて、増強、及び/又は長く維持することができる。このようなヘアケア製品は従来公知の一般的な形態、例えば、シャンプー、リンス、コンディショナー、トリートメント等とすることができる。 In another embodiment, the "retention agent" of the present invention is provided in a hair care product. By applying the product to hair, the oil-in-water emulsion in the retention agent of the present invention adheres to the hair, and the co-administered active ingredients, such as hair protection ingredients (hydrolyzed eggshell membrane, hydrolyzed keratin, hydrolyzed collagen, hydrolyzed silk, hydrolyzed wheat, hydrolyzed wheat protein, hydrolyzed soy protein, glutamic acid, arginine, pyrrolidone carboxylic acid, dimethicone, amodimethicone, polyquaternium-10, chitosan, etc.), hair quality improvement ingredients (stearyltrimonium bromide, cetrimonium bromide, stearyltrimonium chloride, etc.), hair repair ingredients (olive oil, jojoba oil, avocado oil, squalane, isopropyl myristate, isostearyl alcohol, oleyl alcohol, egg yolk fatty oil, adsorbed refined lanolin, soybean oil, etc.), and the like, are dissolved in the hair. By retaining and/or absorbing/adsorbing and retaining active ingredients such as (but not limited to) moisturizing ingredients (hyaluronic acid, glycerin, hydrolyzed eggshell membrane, hydrolyzed keratin, hydrolyzed collagen, hydrolyzed silk, hydrolyzed wheat, hydrolyzed wheat protein, hydrolyzed soy protein, glutamic acid, arginine, pyrrolidone carboxylic acid, egg yolk fatty oil, adsorbed refined lanolin, soybean sterol, cholesterol, ceramide, etc.), the effect of the active ingredient can be enhanced and/or maintained for a longer period of time compared to when the retention agent is not used. Such hair care products can be in the conventional general forms known in the art, such as shampoos, rinses, conditioners, treatments, etc.
以下、実施例により本発明を説明するが、本発明はこれらの実施例に限定されるものではない。 The present invention will be described below with reference to examples, but the present invention is not limited to these examples.
実験1:水中油型エマルジョンの乳化安定性の評価
(1)水中油型エマルジョンの作製
以下の表1の組成にしたがって、各成分を添加、混合し、水中油型エマルジョンを作製した。疎水性物質としては油脂(キャノーラ油)を使用し、増粘多糖類としては、カルボキシメチルセルロース(CMC)、グルコマンナン、グアーガム、κ-カラギーナン、タマリンドガム、ジェランガム、キサンタンガム、ι-カラギーナン、ローカストビーンガム、λ-カラギーナン、対照として非多糖類の増粘剤であるカルボキシルビニルポリマーとポリアクリル酸ナトリウムのいずれか一つを配合した。
Experiment 1: Evaluation of emulsion stability of oil-in-water emulsions (1) Preparation of oil-in-water emulsions Oil-in-water emulsions were prepared by adding and mixing each component according to the composition in Table 1 below. Oil (canola oil) was used as the hydrophobic substance, and carboxymethylcellulose (CMC), glucomannan, guar gum, κ-carrageenan, tamarind gum, gellan gum, xanthan gum, ι-carrageenan, locust bean gum, λ-carrageenan were used as thickening polysaccharides, and either carboxyvinyl polymer or sodium polyacrylate, which are non-polysaccharide thickening agents, was used as a control.
各成分の混合は一度に行い、ハンドブレンダーを用いて20,000rpmにて10分間攪拌して行った。得られた各水中油型エマルジョン(50mL)をコニカルチューブ(Falcon(登録商標)コニカルチューブ50mL)に移し、3000rpmにて1分間で遠心した。次いで、水相、ミセル、油相の厚み(深さ)を目視で観察し、各相の割合(%)を計測して、各組成物の乳化安定性を評価した。評価はミセルの割合が100%であるものを「◎」、ミセルの割合が70%以上かつ100%未満であるものを「〇」、ミセルの割合が70%未満であるものを「×」として行った。 Each component was mixed at once and stirred for 10 minutes at 20,000 rpm using a hand blender. Each resulting oil-in-water emulsion (50 mL) was transferred to a conical tube (Falcon (registered trademark) conical tube 50 mL) and centrifuged at 3000 rpm for 1 minute. The thickness (depth) of the aqueous phase, micelles, and oil phase was then visually observed and the proportion (%) of each phase was measured to evaluate the emulsion stability of each composition. The evaluation was performed with a micelle proportion of 100% as "◎", a micelle proportion of 70% or more but less than 100% as "◯", and a micelle proportion of less than 70% as "X".
なお、以下に記載される表中の各成分の量は、得られた水中油型エマルジョンの量を100質量%とする、質量%の量にて示される。油脂、α-サイクロデキストリン、及び増粘多糖類はいずれも食品添加物(食品グレード)を使用した。 The amount of each component in the table below is shown in mass %, with the amount of the obtained oil-in-water emulsion being 100 mass %. Food additives (food grade) were used for the fats and oils, α-cyclodextrin, and thickening polysaccharides.
(2)結果
水中油型エマルジョンに添加した増粘多糖類と、計測された各相の割合、及び評価結果を表2に示す。水、疎水性物質、α-サイクロデキストリンと共に増粘多糖類を添加、混合することにより水中油型エマルジョンを形成することが可能であるが、上記結果より明らかなとおり、増粘多糖類として、カルボキシメチルセルロース(CMC)、グルコマンナン、グアーガム、κ-カラギーナン、タマリンドガム、ジェランガム、キサンタンガム、ι-カラギーナン、ローカストビーンガム、λ-カラギーナンを用いた場合には、上記条件下においても水中油型エマルジョンのミセル相が維持され、特に高い乳化安定性を示すことが確認された。とりわけ、CMC、グルコマンナン、タマリンドガム、キサンタンガムをそれぞれ添加した場合には、水相及び油相の分離は認められず、顕著に高い乳化安定性が確認された。一方、非多糖類の増粘剤の添加によっては、上記条件下において水相と油相の分離が大きく、乳化安定性が比較的低いことが確認された。
(2) Results The thickening polysaccharides added to the oil-in-water emulsions, the measured ratios of each phase, and the evaluation results are shown in Table 2. It is possible to form an oil-in-water emulsion by adding and mixing a thickening polysaccharide together with water, a hydrophobic substance, and α-cyclodextrin. As is clear from the above results, when carboxymethylcellulose (CMC), glucomannan, guar gum, κ-carrageenan, tamarind gum, gellan gum, xanthan gum, ι-carrageenan, locust bean gum, and λ-carrageenan were used as thickening polysaccharides, the micellar phase of the oil-in-water emulsion was maintained even under the above conditions, and it was confirmed that the emulsion showed particularly high emulsion stability. In particular, when CMC, glucomannan, tamarind gum, and xanthan gum were added, separation of the aqueous phase and the oil phase was not observed, and remarkably high emulsion stability was confirmed. On the other hand, it was confirmed that the addition of a non-polysaccharide thickener caused significant separation of the aqueous phase and the oil phase under the above conditions, resulting in relatively low emulsion stability.
以下の表3の組成にしたがって、各成分を添加、混合し、水中油型エマルジョンを作製した。疎水性物質としては、オイルレッドを1%の量で含む、カルナバロウ、ワセリンワックス(白色ワセリン)、ロジン、シリコーン油のいずれか一つを使用し、増粘多糖類としては、キサンタンガムを配合した。表中の各成分の量は、得られた水中油型エマルジョンの量を100質量%とする、質量%の量にて示される。 Each component was added and mixed according to the composition in Table 3 below to prepare an oil-in-water emulsion. As a hydrophobic substance, one of carnauba wax, petrolatum wax (white petrolatum), rosin, and silicone oil, containing 1% oil red, was used, and xanthan gum was used as a thickening polysaccharide. The amount of each component in the table is shown in mass %, with the amount of the obtained oil-in-water emulsion being 100 mass %.
上記と同様の手法にて各成分の混合、攪拌を行い、得られた各水中油型エマルジョン(50mL)をコニカルチューブ(Falcon(登録商標)コニカルチューブ50mL)に移し、3000rpmにて1分間で遠心した。次いで、水相、ミセル、油相の厚み(深さ)を目視で観察し、各相の割合(%)を計測して、各組成物の乳化安定性を上記と同様に評価した。 The components were mixed and stirred in the same manner as above, and each resulting oil-in-water emulsion (50 mL) was transferred to a conical tube (Falcon (registered trademark) conical tube 50 mL) and centrifuged at 3000 rpm for 1 minute. The thickness (depth) of the aqueous phase, micelles, and oil phase was then visually observed, and the proportion (%) of each phase was measured, and the emulsion stability of each composition was evaluated in the same manner as above.
水中油型エマルジョンに添加した疎水性物質と、計測された各相の割合、及び評価結果を表4に示す。この結果より、油脂だけでなく、その他の疎水性物質を用いた場合においても、水中油型エマルジョンを形成することができ、また上記条件下においても水中油型エマルジョンのミセル相が維持され、高い乳化安定性が得られることが確認された。 The hydrophobic substances added to the oil-in-water emulsion, the measured ratios of each phase, and the evaluation results are shown in Table 4. These results demonstrate that oil-in-water emulsions can be formed using not only oils and fats, but also other hydrophobic substances, and that the micellar phase of the oil-in-water emulsion is maintained even under the above conditions, resulting in high emulsion stability.
実験2:水中油型エマルジョンにおけるα-サイクロデキストリンと増粘多糖類間の相互作用の評価
水溶液中のα-サイクロデキストリンと増粘多糖類との相互作用を評価するため、従来公知の手法に準じた等温滴定型熱量測定(Isothermal Titration Calorimetry;ITC)によりエンタルピー変化(ΔH)を求めた。すなわち、等温滴定カロリメータ(NANO ITC SV;TA Instruments)を用いてα-サイクロデキストリンの水溶液(25g/100mL)に、増粘多糖類の水溶液(0.05g/100mL)を180秒ごとに10μLを25回(75分)にわたって滴下し、25回目(最終)の滴定ピークの面積よりエンタルピー値(μJ)を求めた。対照として非多糖類の増粘剤であるカルボキシルビニルポリマーとポリアクリル酸ナトリウムを用いて、同様にエンタルピー値(μJ)を求めた。
Experiment 2: Evaluation of the interaction between α-cyclodextrin and thickening polysaccharide in oil-in-water emulsion To evaluate the interaction between α-cyclodextrin and thickening polysaccharide in an aqueous solution, the enthalpy change (ΔH) was determined by isothermal titration calorimetry (ITC) according to a conventionally known method. That is, using an isothermal titration calorimeter (NANO ITC SV; TA Instruments), 10 μL of a thickening polysaccharide aqueous solution (0.05 g/100 mL) was dropped every 180 seconds for 25 times (75 minutes) into an aqueous solution of α-cyclodextrin (25 g/100 mL), and the enthalpy value (μJ) was determined from the area of the 25th (final) titration peak. As controls, enthalpy values (μJ) were similarly determined using non-polysaccharide thickeners, carboxyvinyl polymer and sodium polyacrylate.
結果を表5に示す。上記実験1においてとりわけ高い乳化安定性が示された増粘多糖類(CMC、及びキサンタンガム)を用いた場合においてプラスのエンタルピー値、すなわち吸熱反応が認められた。この結果は、増粘多糖類とα-サイクロデキストリンとの間で、水和水を介した相互作用の存在を示唆するものであり、例えば、増粘多糖類に水和していた水分子の一部が、α-サイクロデキストリンと水素結合することが考えられる。通常、水分子間で形成される水素結合は、荷電部位による分子間反発を生じる増粘多糖類とα-サイクロデキストリンとの間で形成される水素結合よりも距離が短くエネルギー値が高い。このため、増粘多糖類に水和していた水分子の一部が、α-サイクロデキストリンと水素結合する場合、エネルギー値の差し引きの結果として吸熱反応を生じるものと考えられる。熱量の移動(プラスのエンタルピー値)は増粘多糖類とα-サイクロデキストリンとの間で生じる相互作用の存在を示唆するものであり、この相互作用が上記実験1において、水中油型エマルジョンに高い乳化安定性を生じる要因であると考えられる。 The results are shown in Table 5. A positive enthalpy value, i.e., an endothermic reaction, was observed when thickening polysaccharides (CMC and xanthan gum), which showed particularly high emulsion stability in Experiment 1 above, were used. This result suggests the existence of an interaction between the thickening polysaccharide and α-cyclodextrin via hydration water; for example, it is thought that some of the water molecules hydrated in the thickening polysaccharide form hydrogen bonds with α-cyclodextrin. Normally, the hydrogen bonds formed between water molecules are shorter in distance and have a higher energy value than the hydrogen bonds formed between the thickening polysaccharide and α-cyclodextrin, which cause intermolecular repulsion due to charged sites. For this reason, it is thought that when some of the water molecules hydrated in the thickening polysaccharide form hydrogen bonds with α-cyclodextrin, an endothermic reaction occurs as a result of the subtraction of energy values. The transfer of heat (positive enthalpy value) suggests the presence of an interaction between the thickening polysaccharide and α-cyclodextrin, and this interaction is thought to be the factor that produces high emulsion stability in the oil-in-water emulsion in Experiment 1 above.
実験3:水中油型エマルジョンの性能評価(風味増強)
(1)水中油型エマルジョン自体の風味評価
以下の表6の組成にしたがって、各成分を添加、混合し、水中油型エマルジョンを作製した。各成分の混合は一度に行い、ハンドブレンダーを用いて20,000rpmにて10分間攪拌して行った。
Experiment 3: Performance evaluation of oil-in-water emulsions (flavor enhancement)
(1) Evaluation of the flavor of the oil-in-water emulsion itself Oil-in-water emulsions were prepared by adding and mixing each component according to the composition in Table 6. Each component was mixed at once and stirred with a hand blender at 20,000 rpm for 10 minutes.
なお、表中の各成分の量は、得られた水中油型エマルジョンの量を100質量%とする、質量%の量にて示される。 The amount of each component in the table is shown in mass %, with the amount of the resulting oil-in-water emulsion being 100 mass %.
対照には、以下の表6の組成にしたがって、油脂以外の成分を混合した後、油脂を添加して、剪断力を加えることなく手混合して(すなわち、水中油型エマルジョンとせず)作製した混合物を用いた。 As a control, a mixture was used that was prepared by mixing the ingredients other than the oil and fat according to the composition in Table 6 below, adding the oil and fat, and then mixing by hand without applying shear force (i.e., not forming an oil-in-water emulsion).
得られた水中油型エマルジョン及び対照の混合物を、それぞれ水に1質量%となる量で加えて、各溶液の風味の有無を、よく訓練された専門のパネラーらが官能評価した。 The resulting oil-in-water emulsion and the control mixture were each added to water in an amount of 1% by mass, and the presence or absence of flavor in each solution was evaluated by a panel of well-trained experts through a sensory test.
結果、水中油型エマルジョン及び対照の混合物はいずれも、何も加えていない水と比べて、匂いに差は認められなかった。 The results showed that neither the oil-in-water emulsion nor the control mixture had a different odor than plain water.
対照の混合物は摂取した際に、水と比べて、油脂に由来するまったり感が少し感じられたが、味の違いは感じられなかった。 When the control mixture was ingested, it had a slight sticky feeling due to the oil compared to water, but no difference in taste was detected.
水中油型エマルジョンについては摂取した際に、水と比べて、口腔内全体が広く覆われている(水中油型エマルジョンが付着している)ように感じられたが、味の違いは感じられなかった。1質量%の水中油型エマルジョン溶液に含まれる油脂の量は、0.13質量%程度でしかなく、油脂に由来する味や匂いが感じられることはないことが確認された。 When the oil-in-water emulsion was ingested, it felt like the entire oral cavity was widely covered (the oil-in-water emulsion was attached) compared to water, but no difference in taste was detected. The amount of fats and oils contained in the 1% by mass oil-in-water emulsion solution was only about 0.13% by mass, and it was confirmed that no taste or smell derived from fats and oils was detected.
(2)水中油型エマルジョンの併用による風味増強の効果I
上記にて得られた1質量%の水中油型エマルジョン溶液、及び1質量%の対照の混合物溶液に、下記表7に記載の各味質の成分を所定の量となるように各溶液に加えて、風味評価のための試料とした(以下、1質量%の水中油型エマルジョン溶液を含む試料を「1%O/W(+)」と記載し、1質量%の対照の混合物溶液を含む試料を(以下、「1%O/W(-)」と記載する)。対照としてさらに、水に各味質の成分だけを同量加えた水溶液(以下、「対照水溶液」と記載する。)を用いた。
(2) Effect of flavor enhancement by combined use of oil-in-water emulsion I
To the 1% by mass oil-in-water emulsion solution obtained above and the 1% by mass control mixture solution, a predetermined amount of each taste component listed in Table 7 below was added to each solution to prepare samples for flavor evaluation (hereinafter, the sample containing 1% by mass oil-in-water emulsion solution will be referred to as "1% O/W(+)" and the sample containing 1% by mass control mixture solution will be referred to as "1% O/W(-)"). Furthermore, as a control, an aqueous solution in which only the same amount of each taste component was added to water (hereinafter, referred to as "control aqueous solution") was used.
下記表7に記載される評価順序で、各試料(10mL)を摂取し、それぞれの味の強度を、よく訓練された専門のパネラーらが、対照水溶液の評価を5とする、10段階で評価した。すすぎは、20mLの水にて2回行った。 Each sample (10 mL) was consumed in the order of evaluation described in Table 7 below, and the intensity of each taste was evaluated by a well-trained panel of experts on a 10-point scale, with the control aqueous solution being rated as 5. Rinsing was performed twice with 20 mL of water.
各試料のそれぞれの味の強度の評価結果を以下の表8に示す(甘味・旨味・酸味・苦味:N=4、塩味:N=3)。 The evaluation results for the intensity of each taste for each sample are shown in Table 8 below (sweetness, umami, sourness, bitterness: N=4, saltiness: N=3).
以上の結果より、味質の成分を水中油型エマルジョンに含めることによって(1%O/W(+))、それぞれの味の強度が顕著に高められることが確認された。味質の成分を水中油型エマルジョンを形成しない混合物に含めた場合(1%O/W(-))においても味の強度がやや高まる傾向が認められたが、その程度は微々たるものであった。 These results confirm that by including flavor components in an oil-in-water emulsion (1% O/W (+)), the intensity of each flavor is significantly increased. When flavor components were included in a mixture that did not form an oil-in-water emulsion (1% O/W (-)), there was also a tendency for the flavor intensity to increase slightly, but the degree of increase was slight.
さらに、1%O/W(+)及び1%O/W(-)について、各試料を摂取した後、1分間における味の強度の変化を、よく訓練された専門のパネラーが、官能評価ソフトウェアFIZZ(Biosystemes社)を用いたTime Intensity(TI)法により評価した。その結果を、図1に示す(甘味:N=4、塩味・苦味:N=5、酸味・旨味:N=3、図1の結果は、各パネラーの結果の平均値を示す)。 In addition, for 1% O/W (+) and 1% O/W (-), the change in taste intensity over one minute after ingestion of each sample was evaluated by well-trained expert panelists using the Time Intensity (TI) method with the sensory evaluation software FIZZ (Biosystemes). The results are shown in Figure 1 (sweetness: N=4, saltiness/bitterness: N=5, sourness/umami: N=3; the results in Figure 1 show the average values of the results for each panelist).
図1の結果より、1%O/W(-)と比べて、1%O/W(+)においては、それぞれの味の喫食直後の立ち上がり、強度、ミドルの厚み、後味の持続性の一以上において高い値が得られることが確認された。 The results in Figure 1 confirm that, compared to 1% O/W (-), 1% O/W (+) achieved higher values in one or more of the following: onset of each flavor immediately after consumption, intensity, thickness of the middle flavor, and persistence of aftertaste.
(3)水中油型エマルジョンの併用による風味増強の効果II
以下の表9の組成にしたがって、各成分を添加、混合し、水中油型エマルジョンを作製した。増粘多糖類として、キサンタンガム、アラビアガム、ペクチン、リン酸架橋でんぷん、ヒドロキシプロピルでんぷん、ヒドロキシプロピル化リン酸架橋でんぷん、トラガントガム、ヒドロキシプロピルセルロース、メチルセロース、ヒドロキシプロピルメチルセルロース、ヒドロキシエチルセルロースを用いて、各成分の混合は一度に行い、ハンドブレンダーを用いて20,000rpmにて10分間攪拌して行った。
(3) Effect of flavor enhancement by combined use of oil-in-water emulsion II
Oil-in-water emulsions were prepared by adding and mixing each component according to the composition in Table 9. The thickening polysaccharides used were xanthan gum, gum arabic, pectin, phosphate cross-linked starch, hydroxypropyl starch, hydroxypropylated phosphate cross-linked starch, tragacanth gum, hydroxypropyl cellulose, methyl cellulose, hydroxypropyl methyl cellulose, and hydroxyethyl cellulose. Each component was mixed at once and stirred with a hand blender at 20,000 rpm for 10 minutes.
なお、表中の各成分の量は、得られた水中油型エマルジョンの量を100質量%とする、質量%の量にて示される。 The amount of each component in the table is shown in mass %, with the amount of the resulting oil-in-water emulsion being 100 mass %.
対照には、以下の表9の組成にしたがって、油脂以外の成分を混合した後、油脂を添加して、剪断力を加えることなく手混合して(すなわち、水中油型エマルジョンとせず)作製した混合物を用いた。 As a control, a mixture was used that was prepared by mixing the ingredients other than the oil and fat according to the composition in Table 9 below, adding the oil and fat, and then mixing by hand without applying shear force (i.e., not forming an oil-in-water emulsion).
得られた水中油型エマルジョン及び対照の混合物を、それぞれ水に1質量%となる量で加えて、1質量%の水中油型エマルジョン溶液、及び1質量%の対照の混合物溶液を調製した。これに食塩を0.6質量%の量となるように各溶液に加えて、風味評価のための試料とした(以下、1質量%の水中油型エマルジョン溶液を含む試料を「1%O/W(+)」と記載し、1質量%の対照の混合物溶液を含む試料を(以下、「1%O/W(-)」と記載する)。対照水溶液としてさらに、水に食塩を0.6質量%の量となるように加えた水溶液を用いた。 The resulting oil-in-water emulsion and the control mixture were each added to water in an amount of 1% by mass to prepare a 1% oil-in-water emulsion solution and a 1% control mixture solution. To each solution, salt was added in an amount of 0.6% by mass to prepare samples for flavor evaluation (hereinafter, the sample containing 1% oil-in-water emulsion solution will be referred to as "1% O/W(+)" and the sample containing 1% control mixture solution will be referred to as "1% O/W(-)"). As a control aqueous solution, an aqueous solution in which salt was added to water in an amount of 0.6% by mass was used.
上記表7に記載される評価順序で、各試料(10mL)を摂取し、それぞれの味の強度を、よく訓練された専門のパネラーらが、対照水溶液の評価を5とする、10段階で評価した。すすぎは、20mLの水にて2回行った。 Each sample (10 mL) was consumed in the order of evaluation described in Table 7 above, and the intensity of each taste was evaluated by a well-trained panel of experts on a 10-point scale, with the control aqueous solution being rated as 5. Rinsing was performed twice with 20 mL of water.
各試料のそれぞれの味の強度の評価結果を以下の表10に示す(N=3)。 The evaluation results for the intensity of each taste for each sample are shown in Table 10 below (N=3).
以上の結果より、用いた増粘多糖類の種類に関わらず、水中油型エマルジョンを含めることによって(1%O/W(+))、味の強度が顕著に高められることが確認された。 These results confirmed that regardless of the type of thickening polysaccharide used, the flavor intensity was significantly increased by including an oil-in-water emulsion (1% O/W(+)).
(4)水中油型エマルジョンの併用・繰り返し摂取による風味増強の効果
上記(2)と同様の方法で調製した味質成分(食塩0.6質量%、又はカフェイン0.2質量%)を加えた1%O/W(+)をそれぞれ4回連続で(すすぎを挟むことなく)摂取し(各10mL)、各回におけるそれぞれの味の強度を、1回目の摂取の評価を5とする、10段階で評価した。評価は、よく訓練された専門のパネラーらにより行った。
(4) Effect of Concomitant and Repeated Ingestion of Oil-in-Water Emulsion A 1% O/W(+) containing flavor components (0.6% by mass salt or 0.2% by mass caffeine) prepared in the same manner as in (2) above was ingested four times in succession (without rinsing) (10 mL each), and the intensity of each flavor was evaluated on a 10-point scale, with the first intake being evaluated as 5. The evaluation was performed by well-trained expert panelists.
各試料のそれぞれの味の強度の評価結果を以下の表11に示す(塩味:N=4、苦味:N=3)。 The evaluation results for the intensity of each taste for each sample are shown in Table 11 below (salty: N=4, bitter: N=3).
以上の結果より、いずれの場合においても水中油型エマルジョンを含む試料の繰り返しの摂取により、味の強度が段階的に高まることが確認された。これは、味質の成分が水中油型エマルジョンと共に口腔内に付着して、蓄積されるためであると考えられる。 These results confirmed that in both cases, the taste intensity gradually increased with repeated ingestion of a sample containing an oil-in-water emulsion. This is thought to be because the taste components adhere to and accumulate in the oral cavity along with the oil-in-water emulsion.
(5)水中油型エマルジョンの別途使用による風味増強の効果I
上記(1)にて調製した水中油型エマルジョンを、それぞれ水に10質量%となる量で加えて、味質の成分を含まない、水中油型エマルジョンの10質量%水溶液を得た(以下、「10%O/W(+)」と記載する)。味質の成分を加えた水溶液(以下、「味質水溶液」と記載する。)には、0.6質量%の食塩水溶液を用いた。
(5) Effect of additional use of oil-in-water emulsion on flavor enhancement I
The oil-in-water emulsions prepared in (1) above were each added to water in an amount of 10% by mass to obtain a 10% by mass aqueous solution of the oil-in-water emulsion not containing taste components (hereinafter referred to as "10% O/W(+)"). A 0.6% by mass saline solution was used as the aqueous solution to which taste components were added (hereinafter referred to as "taste aqueous solution").
評価に際しては、味質水溶液(10mL)を摂取し、味の強度を評価(付着前)した後、口内を洗浄し(20mLの水にてすすぎ×2回)、次いで、10%O/W(+)(10mL)を30秒間口に含んで、口腔内に付着させた後に吐き出し、口内を洗浄し(20mLの水にてすすぎ×2回)、次いで、再度、味質水溶液(10mL)を摂取し、味の強度を評価(付着後)した。評価は、よく訓練された専門のパネラーらが、付着前の味質水溶液の評価を5とする、10段階で評価した。 For the evaluation, the taste solution (10 mL) was ingested, the taste intensity was evaluated (before application), the mouth was washed (rinsed twice with 20 mL of water), and then 10% O/W (+) (10 mL) was held in the mouth for 30 seconds and applied to the oral cavity, after which it was spat out, the mouth was washed (rinsed twice with 20 mL of water), and then the taste solution (10 mL) was ingested again and the taste intensity was evaluated (after application). The evaluation was carried out by well-trained expert panelists on a 10-point scale, with 5 being the rating of the taste solution before application.
得られた評価結果を、以下の表12に示す(N=4)。 The evaluation results obtained are shown in Table 12 below (N=4).
さらに、水中油型エマルジョンを付着させる前及び付着させた後の味質水溶液について、各試料を摂取した後、1分間における味の強度の変化を、よく訓練された専門のパネラーらが、官能評価ソフトウェアFIZZ(Biosystemes社)を用いたTime Intensity(TI)法により評価した結果を、図2に示す(N=4)。 Furthermore, the change in taste intensity over one minute after ingesting each taste solution before and after application of the oil-in-water emulsion was evaluated by well-trained expert panelists using the Time Intensity (TI) method with sensory evaluation software FIZZ (Biosystemes). The results are shown in Figure 2 (N=4).
これらの結果より、味質の成分を予め水中油型エマルジョンの水溶液中に混合させず、口腔内に水中油型エマルジョンを付着させたところに、味質水溶液を摂取するだけでも、味の強度が高まることが確認された。また、図2に示されるように、水中油型エマルジョンを付着させた後に、味質水溶液を摂取した場合には、味の喫食直後の立ち上がり、強度、ミドルの厚み、後味の持続性において高い値が得られることが確認された。これは、味質の成分が付着された水中油型エマルジョンに付着、蓄積して作用するためであると考えられる。 These results confirmed that the flavor intensity was increased simply by ingesting the flavor aqueous solution after applying the oil-in-water emulsion to the oral cavity without mixing the flavor components into the aqueous solution of the oil-in-water emulsion beforehand. In addition, as shown in Figure 2, it was confirmed that when the flavor aqueous solution was ingested after applying the oil-in-water emulsion, high values were obtained for the onset of flavor immediately after consumption, flavor intensity, thickness of the middle taste, and persistence of the aftertaste. This is thought to be because the flavor components adhere to and accumulate in the applied oil-in-water emulsion and act.
(6)水中油型エマルジョンの別途使用による風味増強の効果II
下記表13に記載の各味質の成分を所定の量となるように水に加えて、味質水溶液を調製し、上記(5)に記載の評価方法と同様にして、口腔内を10%O/W(+)で付着させる前後の味質水溶液の各味の強度を評価した。評価は、よく訓練された専門のパネラーらが、それぞれ付着前の味質水溶液の評価を5とする、10段階で評価した。
(6) Effect of additional use of oil-in-water emulsion on flavor enhancement II
The components of each taste listed in Table 13 below were added to water in a predetermined amount to prepare a taste solution, and the taste intensity of each taste solution was evaluated before and after application to the oral cavity at 10% O/W(+) in the same manner as in the evaluation method described in (5) above. The evaluation was performed by well-trained expert panelists on a 10-point scale, with 5 being the evaluation of the taste solution before application.
得られた評価結果を、以下の表13に示す(N=2)。 The evaluation results obtained are shown in Table 13 below (N=2).
以上の結果より、5つの基本味の全てについて、味質の成分を予め水中油型エマルジョンの水溶液中に混合させず、口腔内に水中油型エマルジョンを付着させたところに、味質水溶液を摂取するだけで、味の強度が高まることが確認された。 These results confirmed that for all five basic tastes, the taste components were not mixed into the aqueous solution of the oil-in-water emulsion beforehand, but rather the taste intensity was increased by simply ingesting the aqueous taste solution after applying the oil-in-water emulsion to the oral cavity.
(7)水中油型エマルジョンの併用による辛味成分の風味増強の効果
上記の5つの基本味は全て味覚神経により感知されるものである。一方、辛味や渋味等は、味覚神経ではなく、痛覚や温度覚により感知されるものであることから、上記味質の成分とは区別されるものである。そこで、味質の成分とは異なる成分に対しても、水中油型エマルジョンの併用により同様の効果が得られるか否かを確認した。
(7) Effect of enhancing the flavor of pungent components by the combined use of oil-in-water emulsion The above five basic tastes are all sensed by the gustatory nerves. On the other hand, pungent taste, astringent taste, etc. are not sensed by the gustatory nerves but by pain and temperature senses, and are therefore distinct from the above taste components. Therefore, we confirmed whether the combined use of oil-in-water emulsion could have a similar effect on components other than taste components.
以下の表14の組成にしたがって、各成分を添加、混合し、油脂中に辛味成分を含有する水中油型エマルジョンを作製した。増粘多糖類として、キサンタンガム、アラビアガム、ペクチン、リン酸架橋でんぷん、ヒドロキシプロピルでんぷん、ヒドロキシプロピル化リン酸架橋でんぷん、トラガントガム、ヒドロキシプロピルセルロース、メチルセロース、ヒドロキシプロピルメチルセルロース、ヒドロキシエチルセルロースを用いて、各成分の混合は一度に行い、ポリトロンホモジナイザーを用いて20,000rpmにて1分間攪拌して行った。 According to the composition in Table 14 below, each component was added and mixed to prepare an oil-in-water emulsion containing the pungent component in the oil. As thickening polysaccharides, xanthan gum, gum arabic, pectin, phosphate cross-linked starch, hydroxypropyl starch, hydroxypropylated phosphate cross-linked starch, tragacanth gum, hydroxypropyl cellulose, methyl cellulose, hydroxypropyl methyl cellulose, and hydroxyethyl cellulose were used, and each component was mixed at once and stirred for 1 minute at 20,000 rpm using a Polytron homogenizer.
なお、表中の各成分の量は、得られた水中油型エマルジョンの量を100質量%とする、質量%の量にて示される。
対照には、ラー油を用いた。
The amount of each component in the table is shown as a mass % amount, with the amount of the obtained oil-in-water emulsion being 100 mass %.
Chili oil was used as a control.
評価は、よく訓練された専門のパネラーらが、各試料(10mL)を摂取し、それぞれの味の強度を、対照の評価を5とする、10段階で評価を行った。結果は、表14に示され、各数値は平均値を示す(N=3)。 For the evaluation, a panel of well-trained experts ingested each sample (10 mL) and rated the intensity of each flavor on a 10-point scale, with the control being rated 5. The results are shown in Table 14, and each value represents the average (N=3).
結果、辛味成分を含む水中油型エマルジョンはいずれも、用いた増粘多糖類の種類に関わらず、対照と比べて辛味の強度が高まることが確認された。また、辛味成分を含む水中油型エマルジョンは、摂取後10分以上辛みが持続するが、対照の摂取後に感じられる辛味は2分程度で感じられなくなることが確認された。 The results confirmed that all oil-in-water emulsions containing pungent ingredients had a stronger spiciness than the control, regardless of the type of thickening polysaccharide used. In addition, it was confirmed that the spiciness of the oil-in-water emulsions containing pungent ingredients lasted for more than 10 minutes after ingestion, while the spiciness felt after ingestion of the control disappeared within about 2 minutes.
この結果より、味質の成分とは異なる成分、また油脂中の成分に対しても、水中油型エマルジョンを併用することによって、効果(強度)や持続性を高めることが可能であることが確認された。 These results confirm that it is possible to increase the effect (strength) and duration of effects by using oil-in-water emulsions in combination with ingredients other than taste ingredients, as well as ingredients in oils and fats.
(8)比較例
以下の表15の組成にしたがって、各成分を添加、混合して、乳化組成物を作製した。各成分の混合は、ポリトロンホモジナイザーを用いて20,000rpmにて1分間攪拌して行った。
(8) Comparative Example An emulsion composition was prepared by adding and mixing each component according to the composition in the following Table 15. The components were mixed using a Polytron homogenizer at 20,000 rpm for 1 minute.
評価に際しては、比較例Aと比較例Bのセットに分けて行い、それぞれα-サイクロデキストリン及び増粘多糖類(キサンタンガム)を含まない乳化組成物(A-1,B-1)と比較して、乳化組成物(A-2,B-2)において高い強度の塩味が感じられるか確認した。 The evaluation was carried out by dividing the samples into sets of Comparative Example A and Comparative Example B, and it was confirmed whether the emulsion compositions (A-2, B-2) had a stronger salty taste than the emulsion compositions (A-1, B-1) that did not contain α-cyclodextrin or a thickening polysaccharide (xanthan gum).
評価は、よく訓練された専門のパネラーら(N=3)が、各乳化組成物(A-1,B-1)(10mL)を摂取し、味の強度を評価した後、口内を洗浄し(20mLの水にてすすぎ×2回)、次いで、各乳化組成物(A-2,B-2)を摂取し、味の強度を評価、比較した。 For the evaluation, well-trained expert panelists (N=3) ingested each emulsion composition (A-1, B-1) (10 mL), evaluated the intensity of the flavor, washed their mouths (rinsed twice with 20 mL of water), and then ingested each emulsion composition (A-2, B-2) to evaluate and compare the intensity of the flavor.
比較例Aにおいて、比較例A-1と比較例A-2のいずれも、バター状の形状を有し、塩味はほとんど感じられなかった。比較例A-1と比較例A-2とを比較して、両者の塩味の強度に差は認められなかった。 In Comparative Example A, both Comparative Example A-1 and Comparative Example A-2 had a butter-like shape and had almost no noticeable salty taste. Comparing Comparative Example A-1 and Comparative Example A-2, no difference was observed in the intensity of the salty taste between the two.
比較例Bにおいて、比較例B-1と比較例B-2のいずれも、乳化が不十分であり、油浮きが認められた。比較例B-1と比較例B-2のいずれについても、塩味は感じられるが、後に残る感じはなく、両者の塩味の強度に差は認められなかった。 In Comparative Example B, both Comparative Example B-1 and Comparative Example B-2 were insufficiently emulsified, and oil floating was observed. In both Comparative Example B-1 and Comparative Example B-2, a salty taste was felt, but it did not linger, and no difference was observed in the strength of the salty taste between the two.
実験4:水中油型エマルジョンの性能評価(ヘアケア効果の増強)
以下の表16の組成にしたがって、各成分を添加、混合し、水中油型エマルジョンを作製した。各成分の混合は一度に行い、ハンドブレンダーを用いて20,000rpmにて10分間攪拌して行った。なお、表中の各成分の量は、得られた水中油型エマルジョンの量を100質量%とする、質量%の量にて示される。
Experiment 4: Performance evaluation of oil-in-water emulsions (enhancement of hair care effects)
Each component was added and mixed according to the composition in Table 16 below to prepare an oil-in-water emulsion. Each component was mixed at once and stirred for 10 minutes at 20,000 rpm using a hand blender. The amount of each component in the table is shown in mass %, with the amount of the obtained oil-in-water emulsion being 100 mass %.
得られた水中油型エマルジョンを、市販のヘアコンディショナー(TSUBAKIプレミアムモイスト ヘアコンディショナー(株式会社ファイントゥデイ))に25質量%となる量で加えて、水中油型エマルジョン配合のヘアコンディショナーを調製した。対照には、水中油型エマルジョンを配合していない上記市販のヘアコンディショナーを用いた。 The obtained oil-in-water emulsion was added to a commercially available hair conditioner (TSUBAKI Premium Moist Hair Conditioner (Fine Today Co., Ltd.)) in an amount of 25% by mass to prepare a hair conditioner containing an oil-in-water emulsion. As a control, the above commercially available hair conditioner containing no oil-in-water emulsion was used.
髪をヘアシャンプーで洗浄後、40℃前後のお湯でよくすすぎ、水中油型エマルジョン配合のヘアコンディショナー、又は、対照のヘアコンディショナーを約10g手に取り、髪全体によく塗布して1分程度放置し、その後40℃前後のお湯でよくすすぎ、タオルで水分を取り除き、ドライヤーで乾燥させた後、髪の質感をそれぞれ、パネラーら(N=3)が官能評価した。 After washing the hair with hair shampoo, the hair was rinsed thoroughly with hot water of about 40°C, and then about 10 g of the hair conditioner containing an oil-in-water emulsion or the control hair conditioner was taken in the palm of the hand and thoroughly applied to the entire hair and left for about 1 minute. The hair was then rinsed thoroughly with hot water of about 40°C, and the moisture was removed with a towel and dried with a hair dryer. The texture of the hair was then evaluated by a panel (N=3).
結果、対照のヘアコンディショナーを用いた場合には、髪は非常になめらかで光沢ある感じになったが、静電気的な反発で髪のまとまりは少なく、ハネ等が認められた。 The results showed that when the control hair conditioner was used, the hair felt very smooth and shiny, but due to static electricity repulsion the hair was less manageable and frizz was observed.
一方、水中油型エマルジョン配合のヘアコンディショナーを用いた場合には、対照のヘアコンディショナーを用いた場合と同様に髪は非常になめらかで光沢ある感じになったが、さらに、保湿感のあるしっとりした感じになり、まとまりもよく静電気的なハネ等は認められなかった。この結果は、水中油型エマルジョンを含めることによって、ヘアコンディショナーに含まれる有効成分を髪に、より滞留させることができ、当該有効成分による効果が増強、及び/又は長く維持されたことにより、保湿効果等を高め、ハネ等に影響する髪の表面電位を少なくすることができ、髪同士の反発をより低減しているものと考えられる。 On the other hand, when the hair conditioner containing the oil-in-water emulsion was used, the hair felt very smooth and shiny, just like when the control hair conditioner was used, but it also felt moisturized and smooth, and the hair was easy to manage and no static flyaways were observed. This result is thought to be because the inclusion of an oil-in-water emulsion allows the active ingredients in the hair conditioner to remain in the hair longer, enhancing and/or prolonging the effects of the active ingredients, thereby enhancing the moisturizing effect, reducing the surface electric potential of the hair that affects flyaways, and further reducing the repulsion between hair strands.
以上のとおり、本発明に係る水中油型エマルジョンによれば、所定の部位に付着して、有効成分を保持し、及び/又は吸収・吸着して維持して滞留させることができ、有効成分による効果を増強、及び/又は長く維持することが可能であり、有効成分の滞留剤として、飲食品、医薬品、化粧品など、様々な分野において利用されることが期待されるものである。 As described above, the oil-in-water emulsion of the present invention can adhere to a specific site, retain and/or absorb/adsorb the active ingredient, and retain it, thereby enhancing and/or prolonging the effect of the active ingredient. It is expected that the emulsion will be used as a retention agent for active ingredients in various fields, such as food and beverages, pharmaceuticals, and cosmetics.
Claims (11)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2022211335 | 2022-12-28 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2023514389 Division | 2023-02-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2024095759A true JP2024095759A (en) | 2024-07-10 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2396273T3 (en) | Compositions and methods for oral and personal care | |
BR112018068938B1 (en) | microcapsule | |
CN103222931B (en) | Composition containing menthofuran and menthol | |
AU2019201816B2 (en) | Porous protein particles as carriers for actives | |
AU2010243827A2 (en) | Concentrated, creamy to solid and dry compositions of an oil-in-water emulsion, method for the production thereof and use thereof for producing improved foods in terms of sensory aspects and nutrition physiology | |
JP2000229832A (en) | Skin lotion | |
PL209744B1 (en) | Oral care compositions and methods | |
JP3828946B2 (en) | Substrate composition | |
JP6256770B2 (en) | Oral care composition, tablets, granular drugs | |
US20110189109A1 (en) | Compositions comprising fenugreek hydrocolloids | |
WO2024142417A1 (en) | Active ingredient-retaining agent | |
JP2024095759A (en) | Retention agent for active ingredients | |
JP2000159624A (en) | Cosmetic material | |
JP6431095B2 (en) | Chia seed derived composition | |
JP6505358B2 (en) | Astringent composition | |
JP3766070B2 (en) | Water resistant O / W cosmetics with UV protection effect | |
JPH11255612A (en) | Antimicrobial agent and antimicrobial composition | |
WO2019027006A1 (en) | Cosmetic | |
JP2700465B2 (en) | Toiletries containing lysozyme chloride | |
JPS62114905A (en) | Cosmetic | |
JP6570112B2 (en) | Pharmaceutical manufacturing method | |
WO2023182488A1 (en) | Emulsion composition | |
JP3560424B2 (en) | Antibacterial composition | |
JPWO2016195089A1 (en) | Salivary secretion promoter, mouth dryness inhibitor, mouth moisture additive, and composition | |
JP2000095660A (en) | Skin lotion |